The detection of the level of glucose or other analytes, such as lactate, oxygen or the like, in certain individuals is vitally important to their health. For example, the monitoring of glucose is particularly important to individuals with diabetes. Diabetics may need to monitor glucose levels to determine when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.
Devices have been developed for continuous or automatic monitoring of analytes, such as glucose, in bodily fluid such as in the blood stream or in interstitial fluid. Some of these analyte measuring devices are configured so that at least a portion of the devices are positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user.
Following the sensor insertion, the resulting potential trauma to the skin and/or underlying tissue, for example, by the sensor introducer and/or the sensor itself, may, at times, result in instability of signals monitored by the sensor. This may occur in a number of analyte sensors, but not in all cases. This instability is characterized by a decrease in the sensor signal, and when this occurs, generally, the analyte levels monitored may not be reported, recorded or output to the user.
Embodiments of the subject disclosure include device and methods of determining early signal attenuation (ESA) in signals from analyte sensors. More specifically, embodiments include method, device and system for processing sampled data from analyte sensor, determining a single, fixed, normal sensitivity value associated with the analyte sensor, estimating a windowed offset value associated with the analyte sensor for each available sampled data cluster, computing a time varying offset based on the estimated windowed offset value, and applying the time varying offset and the determined normal sensitivity value to the processed sampled data to estimate an analyte level for the sensor.
Also provided are systems, computer program products, and kits.
Before the present disclosure is described in additional detail, it is to be understood that this disclosure is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosure. That the upper and lower limits of these smaller ranges may independently be included in the smaller ranges is also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.
It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.
The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.
As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure.
The figures shown herein are not necessarily drawn to scale, with some components and features being exaggerated for clarity.
Generally, embodiments of the present disclosure relate to methods and devices for detecting at least one analyte such as glucose in body fluid. In certain embodiments, the present disclosure relates to the continuous and/or automatic in vivo monitoring of the level of an analyte using an analyte sensor.
Accordingly, embodiments include analyte monitoring devices and systems that include an analyte sensor—at least a portion of which is positionable beneath the skin of the user—for the in vivo detection, of an analyte, such as glucose, lactate, and the like, in a body fluid. Embodiments include wholly implantable analyte sensors and analyte sensors in which only a portion of the sensor is positioned under the skin and a portion of the sensor resides above the skin, e.g., for contact to a transmitter, receiver, transceiver, processor, etc. The sensor may be, for example, subcutaneously positionable in a patient for the continuous or periodic monitoring of a level of an analyte in a patient's interstitial fluid. For the purposes of this description, continuous monitoring and periodic monitoring will be used interchangeably, unless noted otherwise. The analyte level may be correlated and/or converted to analyte levels in blood or other fluids. In certain embodiments, an analyte sensor may be positioned in contact with interstitial fluid to detect the level of glucose, which detected glucose may be used to infer the glucose level in the patient's bloodstream. Analyte sensors may be insertable into a vein, artery, or other portion of the body containing fluid. Embodiments of the analyte sensors of the subject disclosure may be configured for monitoring the level of the analyte over a time period which may range from minutes, hours, days, weeks, or longer.
Of interest are analyte sensors, such as glucose sensors, that are capable of in vivo detection of an analyte for about one hour or more, e.g., about a few hours or more, e.g., about a few days or more, e.g., about three or more days, e.g., about five days or more, e.g., about seven days or more, e.g., about several weeks or at least one month. Future analyte levels may be predicted based on information obtained, e.g., the current analyte level at time t0, the rate of change of the analyte, etc. Predictive alarms may notify the user of predicted analyte levels that may be of concern prior in advance of the analyte level reaching the future level. This enables the user an opportunity to take corrective action.
Analytes that may be monitored include, but are not limited to, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. In those embodiments that monitor more than one analyte, the analytes may be monitored at the same or different times.
The analyte monitoring system 100 includes a sensor 101, a data processing unit 102 connectable to the sensor 101, and a primary receiver unit 104 which is configured to communicate with the data processing unit 102 via a communication link 103. In certain embodiments, the primary receiver unit 104 may be further configured to transmit data to a data processing terminal 105 to evaluate or otherwise process or format data received by the primary receiver unit 104. The data processing terminal 105 may be configured to receive data directly from the data processing unit 102 via a communication link which may optionally be configured for bi-directional communication. Further, the data processing unit 102 may include a transmitter or a transceiver to transmit and/or receive data to and/or from the primary receiver unit 104, the data processing terminal 105 or optionally the secondary receiver unit 106.
Also shown in
Only one sensor 101, data processing unit 102 and data processing terminal 105 are shown in the embodiment of the analyte monitoring system 100 illustrated in
The analyte monitoring system 100 may be a continuous monitoring system, or semi-continuous, or a discrete monitoring system. In a multi-component environment, each component may be configured to be uniquely identified by one or more of the other components in the system so that communication conflict may be readily resolved between the various components within the analyte monitoring system 100. For example, unique IDs, communication channels, and the like, may be used.
In certain embodiments, the sensor 101 is physically positioned in or on the body of a user whose analyte level is being monitored. The sensor 101 may be configured to at least periodically sample the analyte level of the user and convert the sampled analyte level into a corresponding signal for transmission by the data processing unit 102. The data processing unit 102 is coupleable to the sensor 101 so that both devices are positioned in or on the user's body, with at least a portion of the analyte sensor 101 positioned transcutaneously. The data processing unit 102 performs data processing functions, where such functions may include but are not limited to, filtering and encoding of data signals, each of which corresponds to a sampled analyte level of the user, for transmission to the primary receiver unit 104 via the communication link 103. In one embodiment, the sensor 101 or the data processing unit 102 or a combined sensor/data processing unit may be wholly implantable under the skin layer of the user.
In one aspect, the primary receiver unit 104 may include an analog interface section including a radio frequency (RF) receiver and an antenna that is configured to communicate with the data processing unit 102 via the communication link 103, a data processing section for processing the received data from the data processing unit 102 such as data decoding, error detection and correction, data clock generation, and/or data bit recovery.
In operation, the primary receiver unit 104 in certain embodiments is configured to synchronize with the data processing unit 102 to uniquely identify the data processing unit 102, based on, for example, an identification information of the data processing unit 102, and thereafter, to periodically receive signals transmitted from the data processing unit 102 associated with the monitored analyte levels detected by the sensor 101.
Referring again to
The data processing terminal 105 may include an infusion device such as an insulin infusion pump or the like, which may be configured to administer insulin to patients, and which may be configured to communicate with the primary receiver unit 104 for receiving, among others, the measured analyte level. Alternatively, the primary receiver unit 104 may be configured to integrate an infusion device therein so that the primary receiver unit 104 is configured to administer insulin (or other appropriate drug) therapy to patients, for example, for administering and modifying basal profiles, as well as for determining appropriate boluses for administration based on, among others, the detected analyte levels received from the data processing unit 102. An infusion device may be an external device or an internal device (wholly implantable in a user).
In particular embodiments, the data processing terminal 105, which may include an insulin pump, may be configured to receive the analyte signals from the data processing unit 102, and thus, incorporate the functions of the primary receiver unit 104 including data processing for managing the patient's insulin therapy and analyte monitoring. In certain embodiments, the communication link 103 as well as one or more of the other communication interfaces shown in
Further shown in
As can be seen in the embodiment of
The processor 204 may be configured to generate and/or process control signals to the various sections of the data processing unit 102 during the operation of the data processing unit 102. In certain embodiments, the processor 204 also includes memory (not shown) for storing data such as the identification information for the data processing unit 102, as well as the data associated with signals received from the sensor 101. The stored information may be retrieved and processed for transmission to the primary receiver unit 104 under the control of the processor 204. Furthermore, the power supply 207 may include a commercially available battery.
In certain embodiments, a manufacturing process of the data processing unit 102 may place the data processing unit 102 in the lower power, non-operating state (i.e., post-manufacture sleep mode). In this manner, the shelf life of the data processing unit 102 may be significantly improved. Moreover, as shown in
Referring back to
Referring yet again to
In certain embodiments, the test strip interface 301 includes a glucose level testing portion to receive a blood (or other body fluid sample) glucose test or information related thereto. For example, the interface may include a test strip port to receive a glucose test strip. The device may determine the glucose level of the test strip, and optionally display (or otherwise notice) the glucose level on the output 310 of the primary receiver unit 104. Any suitable test strip may be employed, e.g., test strips that only require a very small amount (e.g., one microliter or less, e.g., 0.5 microliter or less, e.g., 0.1 microliter or less), of applied sample to the strip in order to obtain accurate glucose information, e.g. FreeStyle® blood glucose test strips from Abbott Diabetes Care, Inc. Glucose information obtained by the in vitro glucose testing device may be used for a variety of purposes, computations, etc. For example, the information may be used to calibrate sensor 101, confirm results of the sensor 101 to increase the confidence thereof (e.g., in instances in which information obtained by sensor 101 is employed in therapy related decisions), etc.
In one aspect, the RF receiver 302 is configured to communicate, via the communication link 103 (
Each of the various components of the primary receiver unit 104 shown in
Referring back to
In further embodiments, the data processing unit 102 and/or the primary receiver unit 104 and/or the secondary receiver unit 106, and/or the data processing terminal/infusion section 105 may be configured to receive the blood glucose value wirelessly over a communication link from, for example, a blood glucose meter. In further embodiments, a user manipulating or using the analyte monitoring system 100 (
Additional detailed descriptions of embodiments of the continuous analyte monitoring system, embodiments of its various components are provided in U.S. Pat. No. 6,175,752 issued Jan. 16, 2001 entitled “Analyte Monitoring Device and Methods of Use”, and in application Ser. No. 10/745,878 filed Dec. 26, 2003, now U.S. Pat. No. 7,811,231, entitled “Continuous Glucose Monitoring System and Methods of Use”, each assigned to the Assignee of the present application, and the disclosures of each of which are incorporated herein by reference for all purposes.
Referring back to
Referring still again to
The embodiment of
In certain embodiments, some or all of the electrodes 501, 502, 503 may be provided on the same side of the substrate 504 in the layered construction as described above, or alternatively, may be provided in a co-planar manner such that two or more electrodes may be positioned on the same plane (e.g., side-by side (e.g., parallel) or angled relative to each other) on the substrate 504. For example, co-planar electrodes may include a suitable spacing there between and/or include dielectric material or insulation material disposed between the conducting layers/electrodes. Furthermore, in certain embodiments one or more of the electrodes 501, 502, 503 may be disposed on opposing sides of the substrate 504. In such embodiments, contact pads may be on the same or different sides of the substrate. For example, an electrode may be on a first side and its respective contact may be on a second side, e.g., a trace connecting the electrode and the contact may traverse through the substrate.
In certain embodiments, the data processing unit 102 may be configured to perform sensor insertion detection and data quality analysis, information pertaining to which may also be transmitted to the primary receiver unit 104 periodically at the predetermined time interval. In turn, the receiver unit 104 may be configured to perform, for example, skin temperature compensation/correction as well as calibration of the sensor data received from the data processing unit 102.
As noted above, analyte sensors may include an analyte-responsive enzyme in a sensing layer. Some analytes, such as oxygen, can be directly electrooxidized or electroreduced on a sensor, and more specifically at least on a working electrode of a sensor. Other analytes, such as glucose and lactate, require the presence of at least one electron transfer agent and/or at least one catalyst to facilitate the electrooxidation or electroreduction of the analyte. Catalysts may also be used for those analytes, such as oxygen, that can be directly electrooxidized or electroreduced on the working electrode. For these analytes, each working electrode includes a sensing layer (see for example sensing layer 508 of
A variety of different sensing layer configurations may be used. In certain embodiments, the sensing layer is deposited on the conductive material of a working electrode. The sensing layer may extend beyond the conductive material of the working electrode. In some cases, the sensing layer may also extend over other electrodes, e.g., over the counter electrode and/or reference electrode (or counter/reference is provided). The sensing layer may be integral with the material of an electrode.
A sensing layer that is in direct contact with the working electrode may contain an electron transfer agent to transfer electrons directly or indirectly between the analyte and the working electrode, and/or a catalyst to facilitate a reaction of the analyte.
A sensing layer that is not in direct contact with the working electrode may include a catalyst that facilitates a reaction of the analyte. However, such sensing layers may not include an electron transfer agent that transfers electrons directly from the working electrode to the analyte, as the sensing layer is spaced apart from the working electrode. One example of this type of sensor is a glucose or lactate sensor which includes an enzyme (e.g., glucose oxidase, glucose dehydrogenase, lactate oxidase, and the like) in the sensing layer. The glucose or lactate may react with a second compound in the presence of the enzyme. The second compound may then be electrooxidized or electroreduced at the electrode. Changes in the signal at the electrode indicate changes in the level of the second compound in the fluid and are proportional to changes in glucose or lactate level and, thus, correlate to the analyte level.
In certain embodiments which include more than one working electrode, one or more of the working electrodes do not have a corresponding sensing layer, or have a sensing layer which does not contain one or more components (e.g., an electron transfer agent and/or catalyst) needed to electrolyze the analyte. Thus, the signal at this working electrode corresponds to background signal which may be removed from the analyte signal obtained from one or more other working electrodes that are associated with fully-functional sensing layers by, for example, subtracting the signal.
In certain embodiments, the sensing layer includes one or more electron transfer agents. Electron transfer agents that may be employed are electroreducible and electrooxidizable ions or molecules having redox potentials that are a few hundred millivolts above or below the redox potential of the standard calomel electrode (SCE). The electron transfer agent may be organic, organometallic, or inorganic.
In certain embodiments, electron transfer agents have structures or charges which prevent or substantially reduce the diffusional loss of the electron transfer agent during the period of time that the sample is being analyzed. For example, electron transfer agents include but are not limited to a redox species, e.g., bound to a polymer which can in turn be disposed on or near the working electrode. The bond between the redox species and the polymer may be covalent, coordinative, or ionic. Although any organic or organometallic redox species may be bound to a polymer and used as an electron transfer agent, in certain embodiments the redox species is a transition metal compound or complex, e.g., osmium, ruthenium, iron, and cobalt compounds or complexes. It will be recognized that many redox species described for use with a polymeric component may also be used, without a polymeric component.
One type of polymeric electron transfer agent contains a redox species covalently bound in a polymeric composition. An example of this type of mediator is poly(vinylferrocene). Another type of electron transfer agent contains an ionically-bound redox species. This type of mediator may include a charged polymer coupled to an oppositely charged redox species. Examples of this type of mediator include a negatively charged polymer coupled to a positively charged redox species such as an osmium or ruthenium polypyridyl cation. Another example of an ionically-bound mediator is a positively charged polymer such as quaternized poly(4-vinyl pyridine) or poly(1-vinyl imidazole) coupled to a negatively charged redox species such as ferricyanide or ferrocyanide. In other embodiments, electron transfer agents include a redox species coordinatively bound to a polymer. For example, the mediator may be formed by coordination of an osmium or cobalt 2,2′-bipyridyl complex to poly(1-vinyl imidazole) or poly(4-vinyl pyridine).
Suitable electron transfer agents are osmium transition metal complexes with one or more ligands, each ligand having a nitrogen-containing heterocycle such as 2,2′-bipyridine, 1,10-phenanthroline, or derivatives thereof. The electron transfer agents may also have one or more ligands covalently bound in a polymer, each ligand having at least one nitrogen-containing heterocycle, such as pyridine, imidazole, or derivatives thereof. The present disclosure may employ electron transfer agents having a redox potential ranging from about −100 mV to about +150 mV versus the standard calomel electrode (SCE), e.g., ranges from about −100 mV to about +150 mV, e.g., ranges from about −50 mV to about +50 mV, e.g., electron transfer agents have osmium redox centers and a redox potential ranging from +50 mV to −150 mV versus SCE.
The sensing layer may also include a catalyst which is capable of catalyzing a reaction of the analyte. The catalyst may also, in some embodiments, act as an electron transfer agent. One example of a suitable catalyst is an enzyme which catalyzes a reaction of the analyte. For example, a catalyst, such as a glucose oxidase, glucose dehydrogenase (e.g., pyrroloquinoline quinone glucose dehydrogenase (PQQ)), or oligosaccharide dehydrogenase), may be used when the analyte of interest is glucose. A lactate oxidase or lactate dehydrogenase may be used when the analyte of interest is lactate. Laccase may be used when the analyte of interest is oxygen or when oxygen is generated or consumed in response to a reaction of the analyte.
In certain embodiments, a catalyst may be attached to a polymer, cross linking the catalyst with another electron transfer agent (which, as described above, may be polymeric). A second catalyst may also be used in certain embodiments. This second catalyst may be used to catalyze a reaction of a product compound resulting from the catalyzed reaction of the analyte. The second catalyst may operate with an electron transfer agent to electrolyze the product compound to generate a signal at the working electrode. Alternatively, a second catalyst may be provided in an interferent-eliminating layer to catalyze reactions that remove interferents.
Certain embodiments include a Wired Enzyme™ sensing layer that works at a gentle oxidizing potential, e.g., a potential of about +40 mV. This sensing layer uses an osmium (Os)-based mediator designed for low potential operation and is stably anchored in a polymeric layer. Accordingly, in certain embodiments the sensing element is a redox active component that includes (1) Osmium-based mediator molecules attached by stable (bidente) ligands anchored to a polymeric backbone, and (2) glucose oxidase enzyme molecules. These two constituents are crosslinked together.
A mass transport limiting layer (not shown), e.g., an analyte flux modulating layer, may be included with the sensor to act as a diffusion-limiting barrier to reduce the rate of mass transport of the analyte, for example, glucose or lactate, into the region around the working electrodes. The mass transport limiting layers are useful in limiting the flux of an analyte to a working electrode in an electrochemical sensor so that the sensor is linearly responsive over a large range of analyte concentrations and is easily calibrated. Mass transport limiting layers may include polymers and may be biocompatible. A mass transport limiting layer may serve many functions, e.g., functionalities of a biocompatible layer and/or interferent-eliminating layer may be provided by the mass transport limiting layer.
In certain embodiments, a mass transport limiting layer is a membrane composed of crosslinked polymers containing heterocyclic nitrogen groups, such as polymers of polyvinylpyridine and polyvinylimidazole. Electrochemical sensors equipped with such membranes have considerable sensitivity and stability, and a large signal-to-noise ratio, in a variety of conditions.
According to certain embodiments, a membrane is formed by crosslinking in situ a polymer, modified with a zwitterionic moiety, a non-pyridine copolymer component, and optionally another moiety that is either hydrophilic or hydrophobic, and/or has other desirable properties, in an alcohol-buffer solution. The modified polymer may be made from a precursor polymer containing heterocyclic nitrogen groups. Optionally, hydrophilic or hydrophobic modifiers may be used to “fine-tune” the permeability of the resulting membrane to an analyte of interest. Optional hydrophilic modifiers, such as poly(ethylene glycol), hydroxyl or polyhydroxyl modifiers, may be used to enhance the biocompatibility of the polymer or the resulting membrane.
A biocompatible layer (not shown) may be provided over at least that portion of the sensor which is subcutaneously inserted into the patient. The biocompatible layer may be incorporated in the interferent-eliminating layer or in the mass transport limiting layer or may be a separate layer. The layer may prevent the penetration of large biomolecules into the electrodes. The biocompatible layer may also prevent protein adhesion to the sensor, formation of blood clots, and other undesirable interactions between the sensor and body. For example, a sensor may be completely or partially covered on its exterior with a biocompatible coating.
An interferent-eliminating layer (not shown) may be included in the sensor. The interferent-eliminating layer may be incorporated in the biocompatible layer or in the mass transport limiting layer or may be a separate layer. Interferents are molecules or other species that are electroreduced or electrooxidized at the electrode, either directly or via an electron transfer agent, to produce a false signal. In one embodiment, a film or membrane prevents the penetration of one or more interferents into the region around the working electrode. In many embodiments, this type of interferent-eliminating layer is much less permeable to one or more of the interferents than to the analyte. An interferent-eliminating layer may include ionic components to reduce the permeability of the interferent-eliminating layer to ionic interferents having the same charge as the ionic components. Another example of an interferent-eliminating layer includes a catalyst for catalyzing a reaction which removes interferents.
A sensor may also include an active agent such as an anticlotting and/or antiglycolytic agent(s) disposed on at least a portion a sensor that is positioned in a user. An anticlotting agent may reduce or eliminate the clotting of blood or other body fluid around the sensor, particularly after insertion of the sensor. Blood clots may foul the sensor or irreproducibly reduce the amount of analyte which diffuses into the sensor. Examples of useful anticlotting agents include heparin and tissue plasminogen activator (TPA), as well as other known anticlotting agents. Embodiments may include an antiglycolytic agent or precursor thereof. The term “antiglycolytic” is used broadly herein to include any substance that at least retards glucose consumption of living cells.
Sensors described herein may be configured to require no system calibration or no user calibration. For example, a sensor may be factory calibrated and need not require further calibrating. In certain embodiments, calibration may be required, but may be done without user intervention, i.e., may be automatic. In those embodiments in which calibration by the user is required, the calibration may be according to a predetermined schedule or may be dynamic, i.e., the time for which may be determined by the system on a real-time basis according to various factors. Calibration may be accomplished using an in vitro test strip or other calibrator, e.g., a small sample test strip such as a test strip that requires less than about 1 microliter of sample (for example FreeStyle® blood glucose monitoring test strips from Abbott Diabetes Care). For example, test strips that require less than about 1 nanoliter of sample may be used. In certain embodiments, a sensor may be calibrated using only one sample of body fluid per calibration event. For example, a user need only lance a body part one time to obtain sample for a calibration event (e.g., for a test strip), or may lance more than one time within a short period of time if an insufficient volume of sample is obtained firstly. Embodiments include obtaining and using multiple samples of body fluid for a given calibration event, where glucose values of each sample are substantially similar. Data obtained from a given calibration event may be used independently to calibrate or combined with data obtained from previous calibration events, e.g., averaged including weighted averaged, filtered and the like, to calibrate.
An analyte system may include an optional alarm system that, e.g., based on information from a processor, warns the patient of a potentially detrimental condition of the analyte. For example, if glucose is the analyte, an alarm system may warn a user of conditions such as hypoglycemia and/or hyperglycemia and/or impending hypoglycemia, and/or impending hyperglycemia. An alarm system may be triggered when analyte levels reach or exceed a threshold value. An alarm system may also, or alternatively, be activated when the rate of change or acceleration of the rate of change in analyte level increase or decrease, reaches or exceeds a threshold rate or acceleration. For example, in the case of a glucose monitoring system, an alarm system may be activated if the rate of change in glucose concentration exceeds a threshold value which might indicate that a hyperglycemic or hypoglycemic condition is likely to occur. A system may also include system alarms that notify a user of system information such as battery condition, calibration, sensor dislodgment, sensor malfunction, etc. Alarms may be, for example, auditory and/or visual. Other sensory-stimulating alarm systems may be used including alarm systems which heat, cool, vibrate, or produce a mild electrical shock when activated.
The subject disclosure also includes sensors used in sensor-based drug delivery systems. The system may provide a drug to counteract the high or low level of the analyte in response to the signals from one or more sensors. Alternatively, the system may monitor the drug concentration to ensure that the drug remains within a desired therapeutic range. The drug delivery system may include one or more (e.g., two or more) sensors, a transmitter, a receiver/display unit, and a drug administration system. In some cases, some or all components may be integrated in a single unit. The sensor-based drug delivery system may use data from the one or more sensors to provide necessary input for a control algorithm/mechanism to adjust the administration of drugs, e.g., automatically or semi-automatically. As an example, a glucose sensor could be used to control and adjust the administration of insulin from an external or implanted insulin pump.
As discussed in further detail below, in accordance with aspects of the present disclosure an offset based model for improving the accuracy of the analyte sensor signals to address abnormal sensor sensitivity event including, for example, early signal (sensitivity) attenuation is provided. More specifically, in accordance with aspects of the present disclosure, when an analyte sensor is experiencing signal attenuation, it is assumed that the associated sensor sensitivity remains constant, and rather, a predetermined signal offset results. Accordingly, determination of the offset and applying the determined offset to analyte sensor signals provide improved accuracy in the monitored analyte levels from the sensor, even in the case where the analyte sensor is experiencing an abnormal sensitivity event such as, for example, early signal attenuation.
In this manner, in one aspect, there is provided a procedure to retrospectively (or in real time) determine a glucose estimate based on sensor signals and available reference measurements from, for example, in vitro testing that maximizes both the optimal accuracy and precision, while minimally susceptible to errors that may be caused by outlier reference value and/or momentary sensor signal degradation sources such as early signal attenuation.
In providing the best glucose estimate, it is found that the simplest transformation from a raw sensor current signal in arbitrary hardware units to a glucose signal in proper glucose concentration units is in fact a linear scaling operation without any offset. The scaling factor is commonly called sensitivity, in which a raw sensor current signal can be translated into glucose concentration units by dividing the signal's value by the sensitivity value. As a result, the nominal aspect of calibration involves using a reasonable amount of information to infer the most accurate and precise estimate of sensitivity.
While this is the case under normal operating conditions, there are several exceptions in which the sensor response to the analyte may be contaminated by other artifacts. An example is during the presence of early signal attenuation (ESA) condition, where, suppose the sensor has been properly calibrated using its true sensitivity, the resulting glucose values are lower than that determined by other means or an identical sensor that is not subject to ESA condition.
In such non-normal operating conditions, the best glucose estimate from the sensor may be determined by retaining the same best estimate of sensitivity as in the nominal case, and in addition, determining the best estimate of a slowly time varying offset. This may be defined as the offset based model. In one aspect, the offset based model assumes that the true gain or sensitivity of the system remains the same throughout the sensor's life, and that non-normal operating conditions such as ESA condition is best represented by a nonzero, slowly time varying offset.
Referring now to the Figures,
Referring again to
Gs(k)=Gr(k)/Sn
where Sn is the normal sensitivity previously computed. For each pairable scaled sensor signal Gs and reference blood glucose measurement (BG) in a window, a difference (DGs) may be determined as follows:
DGs(k)=Gs(k)−BG(k)
where k denotes the time index of a pair.
The difference value (DGs) between each pairable scaled sensor signal Gs to its corresponding reference blood glucose (BG) measurement pair is a reflection of the latest offset. In one aspect, the plurality of these computed offset within this window of reference blood glucose measurement—sensor pairs determine the windowed offset in this window. An example of obtaining a windowed offset using the available data in a window is averaging the difference value (DGs). Yet another example is to take the median value of the difference value (DGs). Under normal operating conditions, the windowed offset is zero.
Referring still again to
Finally, for each one minute sampled analyte data (or any other periodically sampled analyte data from the sensor), the slowly time varying estimated offset Go(k) and the best estimate of the constant Sn are applied to the sampled analyte data to estimate the corresponding glucose value (650). That is, for example, for each of the one minute sampled analyte sensor data Gr(k) which has been lag corrected, temperature compensated, and/or smoothed or filtered, the slowly time varying offset Go(k) is applied with the previously determined normal sensitivity Sn to determine the corresponding estimated glucose value Gf(k) based on the following relationship:
Gf(k)=[Gr(k)/Sn]−Go(k)
Si(k)=Gr(k)/BG
Referring back to
In one embodiment, a least squares fit line is calculated for the sensor rate of change as a function of the corresponding immediate sensitivity (Si) within the time window. The vertical difference between each immediate sensitivity (Si) and the calculated least squares fit line corresponds to a lag residual compensated sensitivity. Furthermore, the intercept at the zero rate of change of this least squares fit line corresponds to the estimate of the latest sensitivity (S0) in the corresponding time window.
It is to be noted that the standard error associated with the least squares fit line may correspond to how the available data fits the lag correction model as well as how much variance is introduced from the zero mean sensitivity error sources. In this context, the zero mean sensitivity error sources are factors that could increase the variance of the sensitivity calculation error without significantly biasing the result in any direction. Examples of such zero mean sensitivity error sources include random sensor error and/or noise, random reference blood glucose error, and insufficient lag correction. Insufficient lag correction may result from using a time constant that is smaller or larger than the actual value, or from using a model that is not sufficiently robust to capture all the transient behavior between blood glucose levels to interstitial glucose levels.
Also, referring back to
Also, the subset of time windows are additionally identified for those with a suitable or sufficient least squares fit line of the sensor rate of change versus immediate sensitivity (Si). The better the fit, the more likely a given window will produce a reliable latest sensitivity value (S0). In one embodiment, the latest sensitivity values (S0) retained are those where the standard sensitivity error (Sse) based on the determined least squares fit line in the lower quartile of the entire time window population.
Additionally, the subset of time windows may further be narrowed to those associated with a relatively low immediate sensitivity (Si) rate of change value. A window with a relatively high immediate sensitivity (Si) rate of change value may indicate a region of poor sensor stability, or a consistent bias in the reference blood glucose values due to unknown circumstances. For example, in one embodiment, only latest sensitivity values (S0) whose rate of change magnitude is in the lower quartile of the entire time window population may be retained. Referring still to
Referring back to
Thereafter, the estimated normal sensitivity determined is confirmed by, for example, comparing it to the median sensitivity computed from all eligible latest sensitivity values (S0) and ensuring that the estimated normal sensitivity is no smaller than the median sensitivity (750). Since numerical determination may incur a certain degree of uncertainty, it is possible that the normal sensitivity candidate may be lower than some clusters of latest sensitivity values (S0) that may be a better candidate for the normal sensitivity estimate. As long as the bottom end of the uncertainty of the latest sensitivity values (S0) is still below the candidate normal sensitivity value, no adjustment may be needed. Otherwise, the normal sensitivity may be adjusted further up to that bottom end limit. An example of computing the bottom end of latest sensitivity values (S0) may include subtracting each latest sensitivity value (S0) with three times (or any other suitable factor) the corresponding standard error (Sse) value. When the mean of this lower bound is higher than the candidate normal sensitivity value, the normal sensitivity should be adjusted to this bound.
In this manner, in accordance with embodiments of the present disclosure, improved real time or retrospective determination of glucose estimate is provided based on analyte sensor data and associated time corresponding reference measurement values (for example, in vitro test results providing associated blood glucose measurements) which improves accuracy and is less prone to abnormal sensor sensitivity events such as, for example, early signal attenuation.
Furthermore, in aspects of the present disclosure, it is contemplated that the highest sustainable in vivo steady state sensitivity associated with an analyte sensor occurs when the sensor is in normal condition. Also, sensitivities determined during reduced or increased mean sensitivity events may be deemed poor or inaccurate representatives of normal sensitivity. Additionally, zero mean sensitivity error sources are not considered to bias the normal sensitivity, and further, lag correction (retrospective or real time) of the analyte sensor raw signal removes most of the rate of change associated sensitivity errors. Moreover, it is considered, in some aspects of the present disclosure, that within a relatively short time window, a single “latest sensitivity” is an accurate representation of the temporal sensitivity—for example, in a five hour time window as in the exemplary discussion set forth above, the “latest sensitivity” may be considered sufficiently representative.
In addition, in a five hour time window, a single effective time constant may be applicable for all available paired points. While different time windows may have different associated time constants, in a steady state condition where other parameters or variables are the same, the time window that has an effective time constant which is closed to an assumed nominal value may have a latest sensitivity value that is more suitable for the normal sensitivity. Finally, in a time window with sufficient number of paired points, the determined sensitivity slope over time may indicate the relative stability of the sensitivity in that time window. As such, again assuming a steady state condition where other parameters or variables are considered to be the same, a time window with a flatter sensitivity slope over time may be a more suitable candidate for the normal sensitivity.
Accordingly, a method in one embodiment includes processing sampled data from analyte sensor, determining a single, fixed, normal sensitivity value associated with the analyte sensor, estimating a windowed offset value associated with the analyte sensor for each available sampled data cluster, computing a time varying offset based on the estimated windowed offset value, and applying the time varying offset and the determined normal sensitivity value to the processed sampled data to estimate an analyte level for the sensor.
Processing the sampled data may include performing retrospective lag correction of the sampled data. Further, processing the sampled data may include smoothing the sampled data from the analyte sensor. In addition, processing the sampled data may include performing temperature correction to the sampled data.
In one aspect, determining the normal sensitivity may include pairing the sampled data from the analyte sensor with one or more time corresponding reference measurement values, where the one or more reference measurement values may include a blood glucose measurement.
A further aspect may include determining an immediate sensitivity value for each paired sampled data and the one or more time corresponding reference measurement values, and also, estimating a latest sensitivity based on the determined immediate sensitivity for each time window.
Yet a further aspect may include defining a subset of the estimated latest sensitivities associated with a subset of the total available time windows corresponding to the respective paired sampled data and the one or more time corresponding reference measurement values.
Additionally, still a further aspect may include weighted averaging the subset of estimated latest sensitivities to determine the normal sensitivity associated with the analyte sensor.
Also, another aspect may include confirming the determined normal sensitivity, where confirming the determined normal sensitivity may include comparing the determined normal sensitivity to a predetermined value, and further, where predetermined value may include a median sensitivity value determined based on the immediate sensitivity associated with each time window.
Also, estimating a windowed offset value in an eligible cluster of data may include collecting one or more pairs of reference measurement value and normal sensitivity adjusted sensor signal to determine the offset of each pair.
The windowed offset value of each pair in a window may be collected to determine a windowed offset value that is most representative of that window.
Additionally, determining a windowed offset value that is most representative of that window may include taking the median of the offset values of each pair in a window, taking the mean of the offset values of each pair in a window, taking a weighted mean of the offset values of each pair in a window, or other means of estimating the most representative offset value given the population of offset values in a window.
Moreover, slowly time varying offset may be determined based on any available windowed offset values using simple interpolation between windowed offset values.
In addition, a slowly time varying offset may be determined by fitting a pre determined mathematical model using any available windowed offset values. One example is a mathematical model similar to the impulse response of a second order model, with the time constants, amplitude, and the start of the response determined by fitting any available windowed offset values.
The estimate of an analyte level for the sensor may be obtained by dividing the latest unscaled value by the normal sensitivity, and then subtracting the result with the latest slowly time varying offset.
An apparatus in accordance with another aspect of the present disclosure includes a data communication interface, one or more processors operatively coupled to the data communication interface and a memory for storing instructions which, when executed by the one or more processors, causes the one or more processors to process sampled data from analyte sensor, determine a single, fixed, normal sensitivity value associated with the analyte sensor, estimate a windowed offset value associated with the analyte sensor for each available sampled data cluster, compute a time varying offset based on the estimated windowed offset value, and apply the time varying offset and the determined normal sensitivity value to the processed sampled data to estimate an analyte level for the sensor.
One or more storage devices having processor readable code embodied thereon, said processor readable code for programming one or more processors to estimate analyte level in accordance with a further aspect of the present disclosure includes processing sampled data from analyte sensor, determining a single, fixed, normal sensitivity value associated with the analyte sensor, estimating a windowed offset value associated with the analyte sensor for each available sampled data cluster, computing a time varying offset based on the estimated windowed offset value, and applying the time varying offset and the determined normal sensitivity value to the processed sampled data to estimate an analyte level for the sensor.
The various processes described above including the processes performed by the data processing unit 102, receiver unit 104/106 or the data processing terminal/infusion section 105 (
Various other modifications and alterations in the structure and method of operation of this disclosure will be apparent to those skilled in the art without departing from the scope and spirit of the embodiments of the present disclosure. Although the present disclosure has been described in connection with particular embodiments, it should be understood that the present disclosure as claimed should not be unduly limited to such particular embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.
The present application is a continuation of U.S. patent application Ser. No. 14/017,195 filed Sep. 3, 2013, now U.S. Pat. No. 10,089,446, which is a continuation of U.S. patent application Ser. No. 13/550,515 filed Jul. 16, 2012, now U.S. Pat. No. 8,532,935, which is a continuation of U.S. patent application Ser. No. 12/362,479 filed Jan. 29, 2009, now U.S. Pat. No. 8,224,415, entitled “Method and Device for Providing Offset Model Based Calibration for Analyte Sensor”, the disclosures of each of which are incorporated herein by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
3581062 | Aston | May 1971 | A |
3926760 | Allen et al. | Dec 1975 | A |
3949388 | Fuller | Apr 1976 | A |
3960497 | Acord et al. | Jun 1976 | A |
3978856 | Michel | Sep 1976 | A |
4036749 | Anderson | Jul 1977 | A |
4055175 | Clemens et al. | Oct 1977 | A |
4129128 | McFarlane | Dec 1978 | A |
4245634 | Albisser et al. | Jan 1981 | A |
4327725 | Cortese et al. | May 1982 | A |
4344438 | Schultz | Aug 1982 | A |
4349728 | Phillips et al. | Sep 1982 | A |
4373527 | Fischell | Feb 1983 | A |
4392849 | Petre et al. | Jul 1983 | A |
4425920 | Bourland et al. | Jan 1984 | A |
4441968 | Emmer et al. | Apr 1984 | A |
4462048 | Ross | Jul 1984 | A |
4478976 | Goertz et al. | Oct 1984 | A |
4494950 | Fischell | Jan 1985 | A |
4509531 | Ward | Apr 1985 | A |
4527240 | Kvitash | Jul 1985 | A |
4538616 | Rogoff | Sep 1985 | A |
4545382 | Higgins et al. | Oct 1985 | A |
4619793 | Lee | Oct 1986 | A |
4671288 | Gough | Jun 1987 | A |
4703756 | Gough et al. | Nov 1987 | A |
4711245 | Higgins et al. | Dec 1987 | A |
4731051 | Fischell | Mar 1988 | A |
4731726 | Allen, III | Mar 1988 | A |
4749985 | Corsberg | Jun 1988 | A |
4757022 | Shults et al. | Jul 1988 | A |
4759366 | Callaghan | Jul 1988 | A |
4777953 | Ash et al. | Oct 1988 | A |
4779618 | Mund et al. | Oct 1988 | A |
4854322 | Ash et al. | Aug 1989 | A |
4871351 | Feingold | Oct 1989 | A |
4890620 | Gough | Jan 1990 | A |
4925268 | Iyer et al. | May 1990 | A |
4947845 | Davis | Aug 1990 | A |
4953552 | DeMarzo | Sep 1990 | A |
4986271 | Wilkins | Jan 1991 | A |
4995402 | Smith et al. | Feb 1991 | A |
5000180 | Kuypers et al. | Mar 1991 | A |
5002054 | Ash et al. | Mar 1991 | A |
5019974 | Beckers | May 1991 | A |
5050612 | Matsumura | Sep 1991 | A |
5055171 | Peck | Oct 1991 | A |
5068536 | Rosenthal | Nov 1991 | A |
5077476 | Rosenthal | Dec 1991 | A |
5082550 | Rishpon et al. | Jan 1992 | A |
5106365 | Hernandez | Apr 1992 | A |
5113869 | Nappholz et al. | May 1992 | A |
5122925 | Inpyn | Jun 1992 | A |
5135004 | Adams et al. | Aug 1992 | A |
5148812 | Verrier et al. | Sep 1992 | A |
5165407 | Wilson et al. | Nov 1992 | A |
5199428 | Obel et al. | Apr 1993 | A |
5202261 | Musho et al. | Apr 1993 | A |
5203326 | Collins | Apr 1993 | A |
5204264 | Kaminer et al. | Apr 1993 | A |
5210778 | Massart | May 1993 | A |
5231988 | Wernicke et al. | Aug 1993 | A |
5246867 | Lakowicz et al. | Sep 1993 | A |
5262035 | Gregg et al. | Nov 1993 | A |
5262305 | Heller et al. | Nov 1993 | A |
5264104 | Gregg et al. | Nov 1993 | A |
5264105 | Gregg et al. | Nov 1993 | A |
5279294 | Anderson et al. | Jan 1994 | A |
5285792 | Sjoquist et al. | Feb 1994 | A |
5293877 | O'Hara et al. | Mar 1994 | A |
5299571 | Mastrototaro | Apr 1994 | A |
5313953 | Yomtov et al. | May 1994 | A |
5320715 | Berg | Jun 1994 | A |
5320725 | Gregg et al. | Jun 1994 | A |
5322063 | Allen et al. | Jun 1994 | A |
5328460 | Lord et al. | Jul 1994 | A |
5330634 | Wong et al. | Jul 1994 | A |
5340722 | Wolfbeis et al. | Aug 1994 | A |
5342789 | Chick et al. | Aug 1994 | A |
5356786 | Heller et al. | Oct 1994 | A |
5360404 | Novacek et al. | Nov 1994 | A |
5365426 | Siegel et al. | Nov 1994 | A |
5372427 | Padovani et al. | Dec 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5379238 | Stark | Jan 1995 | A |
5384547 | Lynk et al. | Jan 1995 | A |
5390671 | Lord et al. | Feb 1995 | A |
5391250 | Cheney, II et al. | Feb 1995 | A |
5400795 | Murphy et al. | Mar 1995 | A |
5408999 | Singh et al. | Apr 1995 | A |
5411647 | Johnson et al. | May 1995 | A |
5425749 | Adams | Jun 1995 | A |
5425868 | Pedersen | Jun 1995 | A |
5431160 | Wilkins | Jul 1995 | A |
5431921 | Thombre | Jul 1995 | A |
5438983 | Falcone | Aug 1995 | A |
5462645 | Albery et al. | Oct 1995 | A |
5472317 | Field et al. | Dec 1995 | A |
5489414 | Schreiber et al. | Feb 1996 | A |
5497772 | Schulman et al. | Mar 1996 | A |
5505828 | Wong et al. | Apr 1996 | A |
5507288 | Bocker et al. | Apr 1996 | A |
5509410 | Hill et al. | Apr 1996 | A |
5514718 | Lewis et al. | May 1996 | A |
5520191 | Karlsson et al. | May 1996 | A |
5531878 | Vadgama et al. | Jul 1996 | A |
5543326 | Heller et al. | Aug 1996 | A |
5552997 | Massart | Sep 1996 | A |
5568400 | Stark et al. | Oct 1996 | A |
5568806 | Cheney, II et al. | Oct 1996 | A |
5569186 | Lord et al. | Oct 1996 | A |
5582184 | Erickson et al. | Dec 1996 | A |
5586553 | Halili et al. | Dec 1996 | A |
5593852 | Heller et al. | Jan 1997 | A |
5601435 | Quy | Feb 1997 | A |
5609575 | Larson et al. | Mar 1997 | A |
5628310 | Rao et al. | May 1997 | A |
5628890 | Carter et al. | May 1997 | A |
5640954 | Pfeiffer et al. | Jun 1997 | A |
5653239 | Pompei et al. | Aug 1997 | A |
5660163 | Schulman et al. | Aug 1997 | A |
5665222 | Heller et al. | Sep 1997 | A |
5711001 | Bussan et al. | Jan 1998 | A |
5711861 | Ward et al. | Jan 1998 | A |
5720295 | Greenhut et al. | Feb 1998 | A |
5733259 | Valcke et al. | Mar 1998 | A |
5735285 | Albert et al. | Apr 1998 | A |
5741211 | Renirie et al. | Apr 1998 | A |
5772586 | Heinonen et al. | Jun 1998 | A |
5785660 | van Lake et al. | Jul 1998 | A |
5791344 | Schulman et al. | Aug 1998 | A |
5792065 | Xue et al. | Aug 1998 | A |
5820551 | Hill et al. | Oct 1998 | A |
5822715 | Worthington et al. | Oct 1998 | A |
5891047 | Lander et al. | Apr 1999 | A |
5899855 | Brown | May 1999 | A |
5914026 | Blubaugh, Jr. et al. | Jun 1999 | A |
5918603 | Brown | Jul 1999 | A |
5925021 | Castellano et al. | Jul 1999 | A |
5935224 | Svancarek et al. | Aug 1999 | A |
5942979 | Luppino | Aug 1999 | A |
5957854 | Besson et al. | Sep 1999 | A |
5960797 | Kramer et al. | Oct 1999 | A |
5961451 | Reber et al. | Oct 1999 | A |
5964993 | Blubaugh, Jr. et al. | Oct 1999 | A |
5965380 | Heller et al. | Oct 1999 | A |
5971922 | Arita et al. | Oct 1999 | A |
5995860 | Sun et al. | Nov 1999 | A |
6001067 | Shults et al. | Dec 1999 | A |
6016443 | Ekwall et al. | Jan 2000 | A |
6021350 | Mathson | Feb 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6038469 | Karlsson et al. | Mar 2000 | A |
6049727 | Crothall | Apr 2000 | A |
6071391 | Gotoh et al. | Jun 2000 | A |
6073031 | Helstab et al. | Jun 2000 | A |
6083710 | Heller et al. | Jul 2000 | A |
6088608 | Schulman et al. | Jul 2000 | A |
6091976 | Pfeiffer et al. | Jul 2000 | A |
6093172 | Funderburk et al. | Jul 2000 | A |
6103033 | Say et al. | Aug 2000 | A |
6108577 | Benser | Aug 2000 | A |
6112116 | Fischell | Aug 2000 | A |
6115622 | Minoz | Sep 2000 | A |
6115628 | Stadler et al. | Sep 2000 | A |
6117290 | Say et al. | Sep 2000 | A |
6119028 | Schulman et al. | Sep 2000 | A |
6120676 | Heller et al. | Sep 2000 | A |
6121009 | Heller et al. | Sep 2000 | A |
6121611 | Lindsay et al. | Sep 2000 | A |
6122351 | Schlueter, Jr. et al. | Sep 2000 | A |
6128526 | Stadler et al. | Oct 2000 | A |
6134461 | Say et al. | Oct 2000 | A |
6143164 | Heller et al. | Nov 2000 | A |
6144837 | Quy | Nov 2000 | A |
6159147 | Lichter et al. | Dec 2000 | A |
6161095 | Brown | Dec 2000 | A |
6162611 | Heller et al. | Dec 2000 | A |
6175752 | Say et al. | Jan 2001 | B1 |
6200265 | Walsh et al. | Mar 2001 | B1 |
6212416 | Ward et al. | Apr 2001 | B1 |
6219574 | Cormier et al. | Apr 2001 | B1 |
6223283 | Chaiken et al. | Apr 2001 | B1 |
6233471 | Berner et al. | May 2001 | B1 |
6233486 | Ekwall et al. | May 2001 | B1 |
6248067 | Causey, III et al. | Jun 2001 | B1 |
6249705 | Snell | Jun 2001 | B1 |
6254586 | Mann et al. | Jul 2001 | B1 |
6256538 | Ekwall | Jul 2001 | B1 |
6264606 | Ekwall et al. | Jul 2001 | B1 |
6270455 | Brown | Aug 2001 | B1 |
6272379 | Fischell et al. | Aug 2001 | B1 |
6275717 | Gross et al. | Aug 2001 | B1 |
6283761 | Joao | Sep 2001 | B1 |
6284478 | Heller et al. | Sep 2001 | B1 |
6293925 | Safabash et al. | Sep 2001 | B1 |
6295506 | Heinonen et al. | Sep 2001 | B1 |
6299757 | Feldman et al. | Oct 2001 | B1 |
6306104 | Cunningham et al. | Oct 2001 | B1 |
6309884 | Cooper et al. | Oct 2001 | B1 |
6329161 | Heller et al. | Dec 2001 | B1 |
6338790 | Feldman et al. | Jan 2002 | B1 |
6348640 | Navot et al. | Feb 2002 | B1 |
6359444 | Grimes | Mar 2002 | B1 |
6360888 | McIvor et al. | Mar 2002 | B1 |
6361503 | Starobin et al. | Mar 2002 | B1 |
6366794 | Moussy et al. | Apr 2002 | B1 |
6377828 | Chaiken et al. | Apr 2002 | B1 |
6377852 | Bornzin et al. | Apr 2002 | B1 |
6377894 | Deweese et al. | Apr 2002 | B1 |
6379301 | Worthington et al. | Apr 2002 | B1 |
6381493 | Stadler et al. | Apr 2002 | B1 |
6387048 | Schulman et al. | May 2002 | B1 |
6405066 | Essenpreis et al. | Jun 2002 | B1 |
6413393 | Van Antwerp et al. | Jul 2002 | B1 |
6424847 | Mastrototaro et al. | Jul 2002 | B1 |
6427088 | Bowman, IV et al. | Jul 2002 | B1 |
6440068 | Brown et al. | Aug 2002 | B1 |
6461496 | Feldman et al. | Oct 2002 | B1 |
6471689 | Joseph et al. | Oct 2002 | B1 |
6478736 | Mault | Nov 2002 | B1 |
6484046 | Say et al. | Nov 2002 | B1 |
6501983 | Natarajan et al. | Dec 2002 | B1 |
6503381 | Gotoh et al. | Jan 2003 | B1 |
6514460 | Fendrock | Feb 2003 | B1 |
6514718 | Heller et al. | Feb 2003 | B2 |
6520326 | McIvor et al. | Feb 2003 | B2 |
6540891 | Stewart et al. | Apr 2003 | B1 |
6544212 | Galley et al. | Apr 2003 | B2 |
6551494 | Heller et al. | Apr 2003 | B1 |
6558320 | Causey, III et al. | May 2003 | B1 |
6558321 | Burd et al. | May 2003 | B1 |
6558351 | Steil et al. | May 2003 | B1 |
6560471 | Heller et al. | May 2003 | B1 |
6561978 | Conn et al. | May 2003 | B1 |
6562001 | Lebel et al. | May 2003 | B2 |
6564105 | Starkweather et al. | May 2003 | B2 |
6565509 | Say et al. | May 2003 | B1 |
6571128 | Lebel et al. | May 2003 | B2 |
6572542 | Houben et al. | Jun 2003 | B1 |
6574490 | Abbink et al. | Jun 2003 | B2 |
6576101 | Heller et al. | Jun 2003 | B1 |
6577899 | Lebel et al. | Jun 2003 | B2 |
6579690 | Bonnecaze et al. | Jun 2003 | B1 |
6585644 | Lebel et al. | Jul 2003 | B2 |
6591125 | Buse et al. | Jul 2003 | B1 |
6592745 | Feldman et al. | Jul 2003 | B1 |
6595919 | Berner et al. | Jul 2003 | B2 |
6600997 | Deweese et al. | Jul 2003 | B2 |
6605200 | Mao et al. | Aug 2003 | B1 |
6605201 | Mao et al. | Aug 2003 | B1 |
6607509 | Bobroff et al. | Aug 2003 | B2 |
6610012 | Mault | Aug 2003 | B2 |
6616819 | Liamos et al. | Sep 2003 | B1 |
6618934 | Feldman et al. | Sep 2003 | B1 |
6622045 | Snell et al. | Sep 2003 | B2 |
6633772 | Ford et al. | Oct 2003 | B2 |
6635014 | Starkweather et al. | Oct 2003 | B2 |
6641533 | Causey, III et al. | Nov 2003 | B2 |
6648821 | Lebel et al. | Nov 2003 | B2 |
6650471 | Doi | Nov 2003 | B2 |
6654625 | Say et al. | Nov 2003 | B1 |
6656114 | Poulson et al. | Dec 2003 | B1 |
6658396 | Tang et al. | Dec 2003 | B1 |
6659948 | Lebel et al. | Dec 2003 | B2 |
6668196 | Villegas et al. | Dec 2003 | B1 |
6675030 | Ciuczak et al. | Jan 2004 | B2 |
6676816 | Mao et al. | Jan 2004 | B2 |
6687546 | Lebel et al. | Feb 2004 | B2 |
6689056 | Kilcoyne et al. | Feb 2004 | B1 |
6694191 | Starkweather et al. | Feb 2004 | B2 |
6695860 | Ward et al. | Feb 2004 | B1 |
6698269 | Baber et al. | Mar 2004 | B2 |
6702857 | Brauker et al. | Mar 2004 | B2 |
6721582 | Trepagnier et al. | Apr 2004 | B2 |
6730200 | Stewart et al. | May 2004 | B1 |
6731985 | Poore et al. | May 2004 | B2 |
6733446 | Lebel et al. | May 2004 | B2 |
6736957 | Forrow et al. | May 2004 | B1 |
6740075 | Lebel et al. | May 2004 | B2 |
6741877 | Shults et al. | May 2004 | B1 |
6746582 | Heller et al. | Jun 2004 | B2 |
6749740 | Liamos et al. | Jun 2004 | B2 |
6758810 | Lebel et al. | Jul 2004 | B2 |
6764581 | Forrow et al. | Jul 2004 | B1 |
6770030 | Schaupp et al. | Aug 2004 | B1 |
6773671 | Lewis et al. | Aug 2004 | B1 |
6790178 | Mault et al. | Sep 2004 | B1 |
6809653 | Mann et al. | Oct 2004 | B1 |
6810290 | Lebel et al. | Oct 2004 | B2 |
6811533 | Lebel et al. | Nov 2004 | B2 |
6811534 | Bowman, IV et al. | Nov 2004 | B2 |
6813519 | Lebel et al. | Nov 2004 | B2 |
6850790 | Berner et al. | Feb 2005 | B2 |
6862465 | Shults et al. | Mar 2005 | B2 |
6865407 | Kimball et al. | Mar 2005 | B2 |
6873268 | Lebel et al. | Mar 2005 | B2 |
6881551 | Heller et al. | Apr 2005 | B2 |
6882940 | Potts et al. | Apr 2005 | B2 |
6892085 | McIvor et al. | May 2005 | B2 |
6893545 | Gotoh et al. | May 2005 | B2 |
6895263 | Shin et al. | May 2005 | B2 |
6895265 | Silver | May 2005 | B2 |
6912413 | Rantala et al. | Jun 2005 | B2 |
6923763 | Kovatchev et al. | Aug 2005 | B1 |
6931327 | Goode, Jr. et al. | Aug 2005 | B2 |
6932892 | Chen et al. | Aug 2005 | B2 |
6932894 | Mao et al. | Aug 2005 | B2 |
6936006 | Sabra | Aug 2005 | B2 |
6942518 | Liamos et al. | Sep 2005 | B2 |
6950708 | Bowman, IV et al. | Sep 2005 | B2 |
6954662 | Freger et al. | Oct 2005 | B2 |
6958705 | Lebel et al. | Oct 2005 | B2 |
6968294 | Gutta et al. | Nov 2005 | B2 |
6971274 | Olin | Dec 2005 | B2 |
6974437 | Lebel et al. | Dec 2005 | B2 |
6990366 | Say et al. | Jan 2006 | B2 |
6997907 | Safabash et al. | Feb 2006 | B2 |
6998247 | Monfre et al. | Feb 2006 | B2 |
7003336 | Holker et al. | Feb 2006 | B2 |
7003340 | Say et al. | Feb 2006 | B2 |
7003341 | Say et al. | Feb 2006 | B2 |
7010345 | Hill et al. | Mar 2006 | B2 |
7011630 | Desai et al. | Mar 2006 | B2 |
7016713 | Gardner et al. | Mar 2006 | B2 |
7016720 | Kroll | Mar 2006 | B2 |
7022072 | Fox et al. | Apr 2006 | B2 |
7022219 | Mansouri et al. | Apr 2006 | B2 |
7024245 | Lebel et al. | Apr 2006 | B2 |
7025425 | Kovatchev et al. | Apr 2006 | B2 |
7029443 | Kroll | Apr 2006 | B2 |
7029444 | Shin et al. | Apr 2006 | B2 |
7041068 | Freeman et al. | May 2006 | B2 |
7041468 | Drucker et al. | May 2006 | B2 |
7043287 | Khalil et al. | May 2006 | B1 |
7052472 | Miller et al. | May 2006 | B1 |
7052483 | Wojcik | May 2006 | B2 |
7056302 | Douglas | Jun 2006 | B2 |
7074307 | Simpson et al. | Jul 2006 | B2 |
7076300 | Kroll et al. | Jul 2006 | B1 |
7081195 | Simpson et al. | Jul 2006 | B2 |
7092891 | Maus et al. | Aug 2006 | B2 |
7096064 | Deno et al. | Aug 2006 | B2 |
7098803 | Mann et al. | Aug 2006 | B2 |
7103412 | Kroll | Sep 2006 | B1 |
7108778 | Simpson et al. | Sep 2006 | B2 |
7110803 | Shults et al. | Sep 2006 | B2 |
7113821 | Sun et al. | Sep 2006 | B1 |
7118667 | Lee | Oct 2006 | B2 |
7123950 | Mannheimer | Oct 2006 | B2 |
7134999 | Brauker et al. | Nov 2006 | B2 |
7136689 | Shults et al. | Nov 2006 | B2 |
7142911 | Boileau et al. | Nov 2006 | B2 |
7153265 | Vachon | Dec 2006 | B2 |
7167818 | Brown | Jan 2007 | B2 |
7171274 | Starkweather et al. | Jan 2007 | B2 |
7183102 | Monfre et al. | Feb 2007 | B2 |
7190988 | Say et al. | Mar 2007 | B2 |
7192450 | Brauker et al. | Mar 2007 | B2 |
7198606 | Boecker et al. | Apr 2007 | B2 |
7225535 | Feldman et al. | Jun 2007 | B2 |
7226978 | Tapsak et al. | Jun 2007 | B2 |
7258673 | Racchini et al. | Aug 2007 | B2 |
7267665 | Steil et al. | Sep 2007 | B2 |
7272436 | Gill et al. | Sep 2007 | B2 |
7276029 | Goode, Jr. et al. | Oct 2007 | B2 |
7278983 | Ireland et al. | Oct 2007 | B2 |
7295867 | Berner et al. | Nov 2007 | B2 |
7297114 | Gill et al. | Nov 2007 | B2 |
7299082 | Feldman et al. | Nov 2007 | B2 |
7310544 | Brister et al. | Dec 2007 | B2 |
7317938 | Lorenz et al. | Jan 2008 | B2 |
7335294 | Heller et al. | Feb 2008 | B2 |
7354420 | Steil et al. | Apr 2008 | B2 |
7364592 | Carr-Brendel et al. | Apr 2008 | B2 |
7366556 | Brister et al. | Apr 2008 | B2 |
7379765 | Petisce et al. | May 2008 | B2 |
7402153 | Steil et al. | Jul 2008 | B2 |
7404796 | Ginsberg | Jul 2008 | B2 |
7424318 | Brister et al. | Sep 2008 | B2 |
7460898 | Brister et al. | Dec 2008 | B2 |
7467003 | Brister et al. | Dec 2008 | B2 |
7468125 | Kraft et al. | Dec 2008 | B2 |
7471972 | Rhodes et al. | Dec 2008 | B2 |
7474992 | Ariyur | Jan 2009 | B2 |
7494465 | Brister et al. | Feb 2009 | B2 |
7497827 | Brister et al. | Mar 2009 | B2 |
7499002 | Blasko et al. | Mar 2009 | B2 |
7502644 | Gill et al. | Mar 2009 | B2 |
7519408 | Rasdal et al. | Apr 2009 | B2 |
7519478 | Bartkowiak et al. | Apr 2009 | B2 |
7523004 | Bartkowiak et al. | Apr 2009 | B2 |
7524287 | Bharmi | Apr 2009 | B2 |
7547281 | Hayes et al. | Jun 2009 | B2 |
7569030 | Lebel et al. | Aug 2009 | B2 |
7583990 | Goode, Jr. et al. | Sep 2009 | B2 |
7591801 | Brauker et al. | Sep 2009 | B2 |
7599726 | Goode, Jr. et al. | Oct 2009 | B2 |
7613491 | Boock et al. | Nov 2009 | B2 |
7615007 | Shults et al. | Nov 2009 | B2 |
7618369 | Hayter et al. | Nov 2009 | B2 |
7620438 | He | Nov 2009 | B2 |
7630748 | Budiman | Dec 2009 | B2 |
7632228 | Brauker et al. | Dec 2009 | B2 |
7635594 | Holmes et al. | Dec 2009 | B2 |
7637868 | Saint et al. | Dec 2009 | B2 |
7640048 | Dobbles et al. | Dec 2009 | B2 |
7699775 | Desai et al. | Apr 2010 | B2 |
7699964 | Feldman et al. | Apr 2010 | B2 |
7711493 | Bartkowiak et al. | May 2010 | B2 |
7736310 | Taub et al. | Jun 2010 | B2 |
7751864 | Buck, Jr. | Jul 2010 | B2 |
7766829 | Sloan et al. | Aug 2010 | B2 |
7771352 | Shults et al. | Aug 2010 | B2 |
7774145 | Bruaker et al. | Aug 2010 | B2 |
7778680 | Goode, Jr. et al. | Aug 2010 | B2 |
7826981 | Goode, Jr. et al. | Nov 2010 | B2 |
7857760 | Brister et al. | Dec 2010 | B2 |
7866026 | Wang et al. | Jan 2011 | B1 |
7885697 | Brister et al. | Feb 2011 | B2 |
7889069 | Fifolt et al. | Feb 2011 | B2 |
7899511 | Shults et al. | Mar 2011 | B2 |
7905833 | Brister et al. | Mar 2011 | B2 |
7914450 | Goode, Jr. et al. | Mar 2011 | B2 |
7920906 | Goode et al. | Apr 2011 | B2 |
7938797 | Estes | May 2011 | B2 |
7946984 | Brister et al. | May 2011 | B2 |
7974672 | Shults et al. | Jul 2011 | B2 |
8060173 | Goode, Jr. et al. | Nov 2011 | B2 |
8116837 | Huang | Feb 2012 | B2 |
8140312 | Hayter et al. | Mar 2012 | B2 |
8160900 | Taub et al. | Apr 2012 | B2 |
8170803 | Kamath et al. | May 2012 | B2 |
8211016 | Budiman | Jul 2012 | B2 |
8216137 | Budiman | Jul 2012 | B2 |
8216138 | McGarraugh et al. | Jul 2012 | B1 |
8224415 | Budiman et al. | Jul 2012 | B2 |
8239166 | Hayter et al. | Aug 2012 | B2 |
8255026 | Al-Ali | Aug 2012 | B1 |
8282549 | Brauker et al. | Oct 2012 | B2 |
8376945 | Hayter et al. | Feb 2013 | B2 |
8444560 | Hayter et al. | May 2013 | B2 |
8457703 | Al-Ali | Jun 2013 | B2 |
8484005 | Hayter et al. | Jul 2013 | B2 |
8532935 | Budiman | Sep 2013 | B2 |
8543354 | Luo et al. | Sep 2013 | B2 |
8571808 | Hayter | Oct 2013 | B2 |
8612163 | Hayter et al. | Dec 2013 | B2 |
8657746 | Roy | Feb 2014 | B2 |
8682615 | Hayter et al. | Mar 2014 | B2 |
9060719 | Hayter et al. | Jun 2015 | B2 |
9113828 | Budiman | Aug 2015 | B2 |
9398872 | Hayter et al. | Jul 2016 | B2 |
9408566 | Hayter et al. | Aug 2016 | B2 |
9483608 | Hayter et al. | Nov 2016 | B2 |
9558325 | Hayter et al. | Jan 2017 | B2 |
20010041831 | Starkweather et al. | Nov 2001 | A1 |
20020016534 | Trepagnier et al. | Feb 2002 | A1 |
20020019022 | Dunn et al. | Feb 2002 | A1 |
20020042090 | Heller et al. | Apr 2002 | A1 |
20020065454 | Lebel et al. | May 2002 | A1 |
20020068860 | Clark | Jun 2002 | A1 |
20020103499 | Perez et al. | Aug 2002 | A1 |
20020106709 | Potts et al. | Aug 2002 | A1 |
20020120186 | Keimel | Aug 2002 | A1 |
20020128594 | Das et al. | Sep 2002 | A1 |
20020143266 | Bock | Oct 2002 | A1 |
20020143372 | Snell et al. | Oct 2002 | A1 |
20020156355 | Gough | Oct 2002 | A1 |
20020161288 | Shin et al. | Oct 2002 | A1 |
20020169635 | Shillingburg | Nov 2002 | A1 |
20020193679 | Malave et al. | Dec 2002 | A1 |
20030004403 | Drinan et al. | Jan 2003 | A1 |
20030023317 | Brauker et al. | Jan 2003 | A1 |
20030023461 | Quintanilla et al. | Jan 2003 | A1 |
20030032867 | Crothall et al. | Feb 2003 | A1 |
20030032874 | Rhodes et al. | Feb 2003 | A1 |
20030042137 | Mao et al. | Mar 2003 | A1 |
20030050546 | Desai et al. | Mar 2003 | A1 |
20030054428 | Monfre et al. | Mar 2003 | A1 |
20030065308 | Lebel et al. | Apr 2003 | A1 |
20030100821 | Heller et al. | May 2003 | A1 |
20030125612 | Fox et al. | Jul 2003 | A1 |
20030130616 | Steil et al. | Jul 2003 | A1 |
20030134347 | Heller et al. | Jul 2003 | A1 |
20030168338 | Gao et al. | Sep 2003 | A1 |
20030176933 | Lebel et al. | Sep 2003 | A1 |
20030187338 | Say et al. | Oct 2003 | A1 |
20030191377 | Robinson et al. | Oct 2003 | A1 |
20030199744 | Buse et al. | Oct 2003 | A1 |
20030199790 | Boecker et al. | Oct 2003 | A1 |
20030208113 | Mault et al. | Nov 2003 | A1 |
20030212317 | Kovatchev et al. | Nov 2003 | A1 |
20030212379 | Bylund et al. | Nov 2003 | A1 |
20030216630 | Jersey-Willuhn et al. | Nov 2003 | A1 |
20030217966 | Tapsak et al. | Nov 2003 | A1 |
20030235817 | Bartkowiak et al. | Dec 2003 | A1 |
20040010186 | Kimball et al. | Jan 2004 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040011671 | Shults et al. | Jan 2004 | A1 |
20040024553 | Monfre et al. | Feb 2004 | A1 |
20040039298 | Abreu | Feb 2004 | A1 |
20040040840 | Mao et al. | Mar 2004 | A1 |
20040045879 | Shults et al. | Mar 2004 | A1 |
20040054263 | Moerman et al. | Mar 2004 | A1 |
20040064068 | DeNuzzio et al. | Apr 2004 | A1 |
20040077962 | Kroll | Apr 2004 | A1 |
20040078065 | Kroll | Apr 2004 | A1 |
20040093167 | Braig et al. | May 2004 | A1 |
20040099529 | Mao et al. | May 2004 | A1 |
20040106858 | Say et al. | Jun 2004 | A1 |
20040122353 | Shahmirian et al. | Jun 2004 | A1 |
20040133164 | Funderburk et al. | Jul 2004 | A1 |
20040135684 | Steinthal et al. | Jul 2004 | A1 |
20040138588 | Saikley et al. | Jul 2004 | A1 |
20040138716 | Kon et al. | Jul 2004 | A1 |
20040142403 | Hetzel et al. | Jul 2004 | A1 |
20040146909 | Duong et al. | Jul 2004 | A1 |
20040152622 | Keith et al. | Aug 2004 | A1 |
20040162678 | Hetzel et al. | Aug 2004 | A1 |
20040167801 | Say et al. | Aug 2004 | A1 |
20040171921 | Say et al. | Sep 2004 | A1 |
20040172307 | Gruber | Sep 2004 | A1 |
20040176672 | Silver et al. | Sep 2004 | A1 |
20040186362 | Brauker et al. | Sep 2004 | A1 |
20040186365 | Jin et al. | Sep 2004 | A1 |
20040193025 | Steil et al. | Sep 2004 | A1 |
20040193090 | Lebel et al. | Sep 2004 | A1 |
20040197846 | Hockersmith et al. | Oct 2004 | A1 |
20040199059 | Brauker et al. | Oct 2004 | A1 |
20040204687 | Mogensen et al. | Oct 2004 | A1 |
20040208780 | Faries, Jr. et al. | Oct 2004 | A1 |
20040225338 | Lebel et al. | Nov 2004 | A1 |
20040236200 | Say et al. | Nov 2004 | A1 |
20040249253 | Racchini et al. | Dec 2004 | A1 |
20040249420 | Olson et al. | Dec 2004 | A1 |
20040254433 | Bandis et al. | Dec 2004 | A1 |
20040254434 | Goodnow et al. | Dec 2004 | A1 |
20040260478 | Schwamm | Dec 2004 | A1 |
20040263354 | Mann et al. | Dec 2004 | A1 |
20040267300 | Mace | Dec 2004 | A1 |
20050003470 | Nelson et al. | Jan 2005 | A1 |
20050004439 | Shin et al. | Jan 2005 | A1 |
20050004494 | Perez et al. | Jan 2005 | A1 |
20050010087 | Banet et al. | Jan 2005 | A1 |
20050010269 | Lebel et al. | Jan 2005 | A1 |
20050016276 | Guan et al. | Jan 2005 | A1 |
20050027177 | Shin et al. | Feb 2005 | A1 |
20050027180 | Goode et al. | Feb 2005 | A1 |
20050027181 | Goode et al. | Feb 2005 | A1 |
20050027462 | Goode et al. | Feb 2005 | A1 |
20050027463 | Goode et al. | Feb 2005 | A1 |
20050031689 | Shults et al. | Feb 2005 | A1 |
20050038332 | Saidara et al. | Feb 2005 | A1 |
20050043598 | Goode, Jr. et al. | Feb 2005 | A1 |
20050049179 | Davidson et al. | Mar 2005 | A1 |
20050049473 | Desai et al. | Mar 2005 | A1 |
20050070774 | Addison et al. | Mar 2005 | A1 |
20050090607 | Tapsak et al. | Apr 2005 | A1 |
20050096511 | Fox et al. | May 2005 | A1 |
20050096512 | Fox et al. | May 2005 | A1 |
20050112169 | Brauker et al. | May 2005 | A1 |
20050113653 | Fox et al. | May 2005 | A1 |
20050114068 | Chey et al. | May 2005 | A1 |
20050115832 | Simpson et al. | Jun 2005 | A1 |
20050121322 | Say et al. | Jun 2005 | A1 |
20050131346 | Douglas | Jun 2005 | A1 |
20050143635 | Kamath et al. | Jun 2005 | A1 |
20050154271 | Rasdal et al. | Jul 2005 | A1 |
20050176136 | Burd et al. | Aug 2005 | A1 |
20050177398 | Watanabe et al. | Aug 2005 | A1 |
20050182306 | Sloan | Aug 2005 | A1 |
20050187720 | Goode, Jr. et al. | Aug 2005 | A1 |
20050192494 | Ginsberg | Sep 2005 | A1 |
20050192557 | Brauker et al. | Sep 2005 | A1 |
20050195930 | Spital et al. | Sep 2005 | A1 |
20050196821 | Monfre et al. | Sep 2005 | A1 |
20050199494 | Say et al. | Sep 2005 | A1 |
20050203360 | Brauker et al. | Sep 2005 | A1 |
20050214892 | Kovatchev et al. | Sep 2005 | A1 |
20050239154 | Feldman et al. | Oct 2005 | A1 |
20050239156 | Drucker et al. | Oct 2005 | A1 |
20050241957 | Mao et al. | Nov 2005 | A1 |
20050245795 | Goode, Jr. et al. | Nov 2005 | A1 |
20050245799 | Brauker et al. | Nov 2005 | A1 |
20050245839 | Stivoric et al. | Nov 2005 | A1 |
20050245904 | Estes et al. | Nov 2005 | A1 |
20050277164 | Drucker et al. | Dec 2005 | A1 |
20050277912 | John | Dec 2005 | A1 |
20050287620 | Heller et al. | Dec 2005 | A1 |
20050288725 | Hettrick et al. | Dec 2005 | A1 |
20060001538 | Kraft et al. | Jan 2006 | A1 |
20060004270 | Bedard et al. | Jan 2006 | A1 |
20060010098 | Goodnow et al. | Jan 2006 | A1 |
20060015020 | Neale et al. | Jan 2006 | A1 |
20060015024 | Brister et al. | Jan 2006 | A1 |
20060016700 | Brister et al. | Jan 2006 | A1 |
20060017923 | Ruchti et al. | Jan 2006 | A1 |
20060019327 | Brister et al. | Jan 2006 | A1 |
20060020186 | Brister et al. | Jan 2006 | A1 |
20060020187 | Brister et al. | Jan 2006 | A1 |
20060020188 | Kamath et al. | Jan 2006 | A1 |
20060020189 | Brister et al. | Jan 2006 | A1 |
20060020190 | Kamath et al. | Jan 2006 | A1 |
20060020191 | Brister et al. | Jan 2006 | A1 |
20060020192 | Brister et al. | Jan 2006 | A1 |
20060025662 | Buse et al. | Feb 2006 | A1 |
20060025663 | Talbot et al. | Feb 2006 | A1 |
20060029177 | Cranford, Jr. et al. | Feb 2006 | A1 |
20060031094 | Cohen et al. | Feb 2006 | A1 |
20060036139 | Brister et al. | Feb 2006 | A1 |
20060036140 | Brister et al. | Feb 2006 | A1 |
20060036141 | Kamath et al. | Feb 2006 | A1 |
20060036142 | Brister et al. | Feb 2006 | A1 |
20060036143 | Brister et al. | Feb 2006 | A1 |
20060036144 | Brister et al. | Feb 2006 | A1 |
20060036145 | Brister et al. | Feb 2006 | A1 |
20060091006 | Wang et al. | May 2006 | A1 |
20060142651 | Brister et al. | Jun 2006 | A1 |
20060155180 | Brister et al. | Jul 2006 | A1 |
20060166629 | Reggiardo | Jul 2006 | A1 |
20060167365 | Bharmi | Jul 2006 | A1 |
20060167517 | Gill et al. | Jul 2006 | A1 |
20060167518 | Gill et al. | Jul 2006 | A1 |
20060167519 | Gill et al. | Jul 2006 | A1 |
20060173260 | Gaoni et al. | Aug 2006 | A1 |
20060173406 | Hayes et al. | Aug 2006 | A1 |
20060173444 | Choy et al. | Aug 2006 | A1 |
20060183984 | Dobbies et al. | Aug 2006 | A1 |
20060183985 | Brister et al. | Aug 2006 | A1 |
20060189851 | Tvig et al. | Aug 2006 | A1 |
20060189863 | Peyser et al. | Aug 2006 | A1 |
20060193375 | Lee | Aug 2006 | A1 |
20060222566 | Brauker et al. | Oct 2006 | A1 |
20060224109 | Steil et al. | Oct 2006 | A1 |
20060226985 | Goodnow et al. | Oct 2006 | A1 |
20060229512 | Petisce et al. | Oct 2006 | A1 |
20060247508 | Fennell | Nov 2006 | A1 |
20060247685 | Bharmi | Nov 2006 | A1 |
20060247985 | Liamos et al. | Nov 2006 | A1 |
20060258929 | Goode et al. | Nov 2006 | A1 |
20060264785 | Dring et al. | Nov 2006 | A1 |
20060272652 | Stocker et al. | Dec 2006 | A1 |
20060281985 | Ward et al. | Dec 2006 | A1 |
20070016381 | Kamath et al. | Jan 2007 | A1 |
20070027381 | Stafford | Feb 2007 | A1 |
20070032706 | Kamath et al. | Feb 2007 | A1 |
20070033074 | Nitzan et al. | Feb 2007 | A1 |
20070056858 | Chen et al. | Mar 2007 | A1 |
20070060803 | Liljeryd et al. | Mar 2007 | A1 |
20070060814 | Stafford | Mar 2007 | A1 |
20070066873 | Kamath et al. | Mar 2007 | A1 |
20070068807 | Feldman et al. | Mar 2007 | A1 |
20070071681 | Gadkar et al. | Mar 2007 | A1 |
20070073129 | Shah et al. | Mar 2007 | A1 |
20070078320 | Stafford | Apr 2007 | A1 |
20070078321 | Mazza et al. | Apr 2007 | A1 |
20070078322 | Stafford | Apr 2007 | A1 |
20070078323 | Reggiardo et al. | Apr 2007 | A1 |
20070095661 | Wang et al. | May 2007 | A1 |
20070106135 | Sloan et al. | May 2007 | A1 |
20070108048 | Wang et al. | May 2007 | A1 |
20070118030 | Bruce et al. | May 2007 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070124002 | Estes et al. | May 2007 | A1 |
20070129621 | Kellogg et al. | Jun 2007 | A1 |
20070149875 | Ouyang et al. | Jun 2007 | A1 |
20070156033 | Causey, III et al. | Jul 2007 | A1 |
20070163880 | Woo et al. | Jul 2007 | A1 |
20070168224 | Letzt et al. | Jul 2007 | A1 |
20070173706 | Neinast et al. | Jul 2007 | A1 |
20070173709 | Petisce et al. | Jul 2007 | A1 |
20070173710 | Petisce et al. | Jul 2007 | A1 |
20070173761 | Kanderian et al. | Jul 2007 | A1 |
20070179349 | Hoyme et al. | Aug 2007 | A1 |
20070179352 | Randlov et al. | Aug 2007 | A1 |
20070179434 | Weinert et al. | Aug 2007 | A1 |
20070191701 | Feldman et al. | Aug 2007 | A1 |
20070199818 | Petyt et al. | Aug 2007 | A1 |
20070202562 | Curry et al. | Aug 2007 | A1 |
20070203407 | Hoss et al. | Aug 2007 | A1 |
20070203966 | Brauker et al. | Aug 2007 | A1 |
20070213657 | Jennewine et al. | Sep 2007 | A1 |
20070227911 | Wang et al. | Oct 2007 | A1 |
20070232877 | He | Oct 2007 | A1 |
20070232878 | Kovatchev et al. | Oct 2007 | A1 |
20070232880 | Siddiqui et al. | Oct 2007 | A1 |
20070233013 | Schoenberg et al. | Oct 2007 | A1 |
20070235331 | Simpson et al. | Oct 2007 | A1 |
20070249922 | Peyser et al. | Oct 2007 | A1 |
20070255321 | Gerber et al. | Nov 2007 | A1 |
20070282299 | Hellwig | Dec 2007 | A1 |
20070299617 | Willis | Dec 2007 | A1 |
20080004515 | Jennewine et al. | Jan 2008 | A1 |
20080004601 | Jennewine et al. | Jan 2008 | A1 |
20080009692 | Stafford | Jan 2008 | A1 |
20080012701 | Kass et al. | Jan 2008 | A1 |
20080017522 | Heller et al. | Jan 2008 | A1 |
20080021666 | Goode, Jr. et al. | Jan 2008 | A1 |
20080021972 | Huelskamp et al. | Jan 2008 | A1 |
20080029391 | Mao et al. | Feb 2008 | A1 |
20080033254 | Kamath et al. | Feb 2008 | A1 |
20080039702 | Hayter et al. | Feb 2008 | A1 |
20080045824 | Tapsak et al. | Feb 2008 | A1 |
20080058625 | McGarraugh et al. | Mar 2008 | A1 |
20080064937 | McGarraugh et al. | Mar 2008 | A1 |
20080066305 | Wang et al. | Mar 2008 | A1 |
20080071156 | Brister et al. | Mar 2008 | A1 |
20080071157 | McGarraugh et al. | Mar 2008 | A1 |
20080071158 | McGarraugh et al. | Mar 2008 | A1 |
20080081977 | Hayter et al. | Apr 2008 | A1 |
20080083617 | Simpson et al. | Apr 2008 | A1 |
20080086042 | Brister et al. | Apr 2008 | A1 |
20080086044 | Brister et al. | Apr 2008 | A1 |
20080086273 | Shults et al. | Apr 2008 | A1 |
20080097289 | Steil et al. | Apr 2008 | A1 |
20080102441 | Chen et al. | May 2008 | A1 |
20080108942 | Brister et al. | May 2008 | A1 |
20080119703 | Brister et al. | May 2008 | A1 |
20080119708 | Budiman | May 2008 | A1 |
20080139910 | Mastrototaro et al. | Jun 2008 | A1 |
20080148873 | Wang | Jun 2008 | A1 |
20080154513 | Kovatchev et al. | Jun 2008 | A1 |
20080161666 | Feldman et al. | Jul 2008 | A1 |
20080167543 | Say et al. | Jul 2008 | A1 |
20080172205 | Breton et al. | Jul 2008 | A1 |
20080177149 | Weinert et al. | Jul 2008 | A1 |
20080177165 | Blomquist et al. | Jul 2008 | A1 |
20080183060 | Steil et al. | Jul 2008 | A1 |
20080183061 | Goode et al. | Jul 2008 | A1 |
20080183399 | Goode et al. | Jul 2008 | A1 |
20080188731 | Brister et al. | Aug 2008 | A1 |
20080188796 | Steil et al. | Aug 2008 | A1 |
20080189051 | Goode et al. | Aug 2008 | A1 |
20080194934 | Ray et al. | Aug 2008 | A1 |
20080194935 | Brister et al. | Aug 2008 | A1 |
20080194936 | Goode et al. | Aug 2008 | A1 |
20080194937 | Goode et al. | Aug 2008 | A1 |
20080194938 | Brister et al. | Aug 2008 | A1 |
20080195232 | Carr-Brendel et al. | Aug 2008 | A1 |
20080195967 | Goode et al. | Aug 2008 | A1 |
20080197024 | Simpson et al. | Aug 2008 | A1 |
20080200788 | Brister et al. | Aug 2008 | A1 |
20080200789 | Brister et al. | Aug 2008 | A1 |
20080200791 | Simpson et al. | Aug 2008 | A1 |
20080201325 | Doniger et al. | Aug 2008 | A1 |
20080208025 | Shults et al. | Aug 2008 | A1 |
20080208113 | Damiano et al. | Aug 2008 | A1 |
20080214910 | Buck | Sep 2008 | A1 |
20080214915 | Brister et al. | Sep 2008 | A1 |
20080214918 | Brister et al. | Sep 2008 | A1 |
20080228051 | Shults et al. | Sep 2008 | A1 |
20080228054 | Shults et al. | Sep 2008 | A1 |
20080234943 | Ray et al. | Sep 2008 | A1 |
20080242961 | Brister et al. | Oct 2008 | A1 |
20080242963 | Essenpreis et al. | Oct 2008 | A1 |
20080255434 | Hayter et al. | Oct 2008 | A1 |
20080255437 | Hayter | Oct 2008 | A1 |
20080255438 | Saidara et al. | Oct 2008 | A1 |
20080255808 | Hayter | Oct 2008 | A1 |
20080256048 | Hayter | Oct 2008 | A1 |
20080262469 | Brister et al. | Oct 2008 | A1 |
20080267823 | Wang et al. | Oct 2008 | A1 |
20080275313 | Brister et al. | Nov 2008 | A1 |
20080278332 | Fennel et al. | Nov 2008 | A1 |
20080287761 | Hayter | Nov 2008 | A1 |
20080287762 | Hayter | Nov 2008 | A1 |
20080287763 | Hayter | Nov 2008 | A1 |
20080287764 | Rasdal et al. | Nov 2008 | A1 |
20080287765 | Rasdal et al. | Nov 2008 | A1 |
20080287766 | Rasdal et al. | Nov 2008 | A1 |
20080288180 | Hayter | Nov 2008 | A1 |
20080288204 | Hayter et al. | Nov 2008 | A1 |
20080296155 | Shults et al. | Dec 2008 | A1 |
20080300572 | Rankers et al. | Dec 2008 | A1 |
20080306368 | Goode et al. | Dec 2008 | A1 |
20080306434 | Dobbles et al. | Dec 2008 | A1 |
20080306435 | Kamath et al. | Dec 2008 | A1 |
20080306444 | Brister et al. | Dec 2008 | A1 |
20080312841 | Hayter | Dec 2008 | A1 |
20080312842 | Hayter | Dec 2008 | A1 |
20080312844 | Hayter et al. | Dec 2008 | A1 |
20080312845 | Hayter et al. | Dec 2008 | A1 |
20080314395 | Kovatchev et al. | Dec 2008 | A1 |
20080319279 | Ramsay et al. | Dec 2008 | A1 |
20080319295 | Bernstein et al. | Dec 2008 | A1 |
20080319296 | Bernstein et al. | Dec 2008 | A1 |
20090005665 | Hayter et al. | Jan 2009 | A1 |
20090005666 | Shin et al. | Jan 2009 | A1 |
20090006034 | Hayter et al. | Jan 2009 | A1 |
20090006061 | Thukral et al. | Jan 2009 | A1 |
20090006133 | Weinert et al. | Jan 2009 | A1 |
20090012376 | Agus | Jan 2009 | A1 |
20090012379 | Goode et al. | Jan 2009 | A1 |
20090018424 | Kamath et al. | Jan 2009 | A1 |
20090018425 | Ouyang et al. | Jan 2009 | A1 |
20090030293 | Cooper et al. | Jan 2009 | A1 |
20090030294 | Petisce et al. | Jan 2009 | A1 |
20090033482 | Hayter et al. | Feb 2009 | A1 |
20090036747 | Hayter et al. | Feb 2009 | A1 |
20090036758 | Brauker et al. | Feb 2009 | A1 |
20090036760 | Hayter | Feb 2009 | A1 |
20090036763 | Brauker et al. | Feb 2009 | A1 |
20090043181 | Brauker et al. | Feb 2009 | A1 |
20090043182 | Brauker et al. | Feb 2009 | A1 |
20090043525 | Brauker et al. | Feb 2009 | A1 |
20090043541 | Brauker et al. | Feb 2009 | A1 |
20090043542 | Brauker et al. | Feb 2009 | A1 |
20090045055 | Rhodes et al. | Feb 2009 | A1 |
20090048503 | Dalal et al. | Feb 2009 | A1 |
20090054745 | Jennewine et al. | Feb 2009 | A1 |
20090054748 | Feldman et al. | Feb 2009 | A1 |
20090054749 | He | Feb 2009 | A1 |
20090054753 | Robinson et al. | Feb 2009 | A1 |
20090055149 | Hayter et al. | Feb 2009 | A1 |
20090062633 | Brauker et al. | Mar 2009 | A1 |
20090062635 | Brauker et al. | Mar 2009 | A1 |
20090062767 | VanAntwerp et al. | Mar 2009 | A1 |
20090063402 | Hayter | Mar 2009 | A1 |
20090069649 | Budiman | Mar 2009 | A1 |
20090076356 | Simpson et al. | Mar 2009 | A1 |
20090076360 | Brister et al. | Mar 2009 | A1 |
20090076361 | Kamath et al. | Mar 2009 | A1 |
20090082693 | Stafford | Mar 2009 | A1 |
20090085768 | Patel et al. | Apr 2009 | A1 |
20090099436 | Brister et al. | Apr 2009 | A1 |
20090105560 | Solomon | Apr 2009 | A1 |
20090105570 | Sloan et al. | Apr 2009 | A1 |
20090105636 | Hayter et al. | Apr 2009 | A1 |
20090112478 | Mueller, Jr. et al. | Apr 2009 | A1 |
20090112626 | Talbot et al. | Apr 2009 | A1 |
20090118589 | Ueshima et al. | May 2009 | A1 |
20090124877 | Goode, Jr. et al. | May 2009 | A1 |
20090124878 | Goode et al. | May 2009 | A1 |
20090124879 | Brister et al. | May 2009 | A1 |
20090124964 | Leach et al. | May 2009 | A1 |
20090131768 | Simpson et al. | May 2009 | A1 |
20090131769 | Leach et al. | May 2009 | A1 |
20090131776 | Simpson et al. | May 2009 | A1 |
20090131777 | Simpson et al. | May 2009 | A1 |
20090137886 | Shariati et al. | May 2009 | A1 |
20090137887 | Shariati et al. | May 2009 | A1 |
20090143659 | Li et al. | Jun 2009 | A1 |
20090143660 | Brister et al. | Jun 2009 | A1 |
20090143725 | Peyser et al. | Jun 2009 | A1 |
20090149728 | Van Antwerp et al. | Jun 2009 | A1 |
20090156919 | Brister et al. | Jun 2009 | A1 |
20090156924 | Shariati et al. | Jun 2009 | A1 |
20090163790 | Brister et al. | Jun 2009 | A1 |
20090163791 | Brister et al. | Jun 2009 | A1 |
20090163855 | Shin et al. | Jun 2009 | A1 |
20090164190 | Hayter | Jun 2009 | A1 |
20090164239 | Hayter et al. | Jun 2009 | A1 |
20090164251 | Hayter | Jun 2009 | A1 |
20090178459 | Li et al. | Jul 2009 | A1 |
20090182217 | Li et al. | Jul 2009 | A1 |
20090182517 | Gandhi et al. | Jul 2009 | A1 |
20090192366 | Mensinger et al. | Jul 2009 | A1 |
20090192380 | Shariati et al. | Jul 2009 | A1 |
20090192722 | Shariati et al. | Jul 2009 | A1 |
20090192724 | Brauker et al. | Jul 2009 | A1 |
20090192745 | Kamath et al. | Jul 2009 | A1 |
20090192751 | Kamath et al. | Jul 2009 | A1 |
20090198118 | Hayter et al. | Aug 2009 | A1 |
20090203981 | Brauker et al. | Aug 2009 | A1 |
20090204341 | Brauker et al. | Aug 2009 | A1 |
20090216103 | Brister et al. | Aug 2009 | A1 |
20090240120 | Mensinger et al. | Sep 2009 | A1 |
20090240128 | Mensinger et al. | Sep 2009 | A1 |
20090240193 | Mensinger et al. | Sep 2009 | A1 |
20090242399 | Kamath et al. | Oct 2009 | A1 |
20090242425 | Kamath et al. | Oct 2009 | A1 |
20090247855 | Boock et al. | Oct 2009 | A1 |
20090247856 | Boock et al. | Oct 2009 | A1 |
20090247857 | Harper et al. | Oct 2009 | A1 |
20090253973 | Bashan et al. | Oct 2009 | A1 |
20090257911 | Thomas et al. | Oct 2009 | A1 |
20090281407 | Budiman | Nov 2009 | A1 |
20090287073 | Boock et al. | Nov 2009 | A1 |
20090287074 | Shults et al. | Nov 2009 | A1 |
20090294277 | Thomas et al. | Dec 2009 | A1 |
20090299155 | Yang et al. | Dec 2009 | A1 |
20090299156 | Simpson et al. | Dec 2009 | A1 |
20090299162 | Brauker et al. | Dec 2009 | A1 |
20090299276 | Brauker et al. | Dec 2009 | A1 |
20100010324 | Brauker et al. | Jan 2010 | A1 |
20100010331 | Brauker et al. | Jan 2010 | A1 |
20100010332 | Brauker et al. | Jan 2010 | A1 |
20100057040 | Hayter | Mar 2010 | A1 |
20100057041 | Hayter | Mar 2010 | A1 |
20100057042 | Hayter | Mar 2010 | A1 |
20100057044 | Hayter | Mar 2010 | A1 |
20100057057 | Hayter et al. | Mar 2010 | A1 |
20100063372 | Potts et al. | Mar 2010 | A1 |
20100064764 | Hayter et al. | Mar 2010 | A1 |
20100081906 | Hayter et al. | Apr 2010 | A1 |
20100081909 | Budiman et al. | Apr 2010 | A1 |
20100081953 | Syeda-Mahmood et al. | Apr 2010 | A1 |
20100121167 | McGarraugh et al. | May 2010 | A1 |
20100141656 | Krieftewirth | Jun 2010 | A1 |
20100152561 | Goodnow et al. | Jun 2010 | A1 |
20100160759 | Celentano et al. | Jun 2010 | A1 |
20100168538 | Keenan et al. | Jul 2010 | A1 |
20100168546 | Kamath et al. | Jul 2010 | A1 |
20100174266 | Estes | Jul 2010 | A1 |
20100191085 | Budiman | Jul 2010 | A1 |
20100204557 | Kiaie et al. | Aug 2010 | A1 |
20100230285 | Hoss et al. | Sep 2010 | A1 |
20100234710 | Budiman et al. | Sep 2010 | A1 |
20100261987 | Kamath et al. | Oct 2010 | A1 |
20100280441 | Willinska et al. | Nov 2010 | A1 |
20100312176 | Lauer et al. | Dec 2010 | A1 |
20110024043 | Boock et al. | Feb 2011 | A1 |
20110024307 | Simpson et al. | Feb 2011 | A1 |
20110027127 | Simpson et al. | Feb 2011 | A1 |
20110027453 | Boock et al. | Feb 2011 | A1 |
20110027458 | Boock et al. | Feb 2011 | A1 |
20110028815 | Simpson et al. | Feb 2011 | A1 |
20110028816 | Simpson et al. | Feb 2011 | A1 |
20110029247 | Kalathil | Feb 2011 | A1 |
20110040163 | Telson et al. | Feb 2011 | A1 |
20110060530 | Fennell | Mar 2011 | A1 |
20110077490 | Simpson et al. | Mar 2011 | A1 |
20110112696 | Yodfat et al. | May 2011 | A1 |
20110148905 | Simmons et al. | Jun 2011 | A1 |
20110208027 | Wagner et al. | Aug 2011 | A1 |
20110208155 | Palerm et al. | Aug 2011 | A1 |
20110257895 | Brauker et al. | Oct 2011 | A1 |
20110263958 | Brauker et al. | Oct 2011 | A1 |
20110320130 | Valdes et al. | Dec 2011 | A1 |
20120078071 | Bohm et al. | Mar 2012 | A1 |
20120108934 | Valdes et al. | May 2012 | A1 |
20120165626 | Irina et al. | Jun 2012 | A1 |
20120165640 | Galley et al. | Jun 2012 | A1 |
20120173200 | Breton et al. | Jul 2012 | A1 |
20120209099 | Ljuhs et al. | Aug 2012 | A1 |
20120215462 | Goode et al. | Aug 2012 | A1 |
20120245447 | Karan et al. | Sep 2012 | A1 |
20120277565 | Budiman | Nov 2012 | A1 |
20120283542 | McGarraugh | Nov 2012 | A1 |
20120318670 | Karinka et al. | Dec 2012 | A1 |
20130035575 | Mayou et al. | Feb 2013 | A1 |
20130137953 | Harper et al. | May 2013 | A1 |
20130231541 | Hayter et al. | Sep 2013 | A1 |
20130324823 | Koski et al. | Dec 2013 | A1 |
20140005499 | Catt et al. | Jan 2014 | A1 |
20140046160 | Terashima et al. | Feb 2014 | A1 |
20140088392 | Bernstein et al. | Mar 2014 | A1 |
20140121488 | Budiman | May 2014 | A1 |
20140221966 | Buckingham et al. | Aug 2014 | A1 |
20150216456 | Budiman | Aug 2015 | A1 |
20150241407 | Ou et al. | Aug 2015 | A1 |
20150366510 | Budiman | Dec 2015 | A1 |
20160022221 | Ou et al. | Jan 2016 | A1 |
20160302701 | Bhavaraju et al. | Oct 2016 | A1 |
Number | Date | Country |
---|---|---|
0098592 | Jan 1984 | EP |
0127958 | Dec 1984 | EP |
0320109 | Jun 1989 | EP |
0353328 | Feb 1990 | EP |
0390390 | Oct 1990 | EP |
0396788 | Nov 1990 | EP |
0472411 | Feb 1992 | EP |
0286118 | Jan 1995 | EP |
0867146 | Sep 1998 | EP |
1048264 | Nov 2000 | EP |
1419731 | May 2004 | EP |
0939602 | Sep 2004 | EP |
1850909 | Apr 2010 | EP |
1677668 | Jul 2010 | EP |
WO-1996025089 | Aug 1996 | WO |
WO-1996035370 | Nov 1996 | WO |
WO-1997015227 | May 1997 | WO |
WO-1998035053 | Aug 1998 | WO |
WO-1999056613 | Nov 1999 | WO |
WO-2000049940 | Aug 2000 | WO |
WO-2000059370 | Oct 2000 | WO |
WO-2000074753 | Dec 2000 | WO |
WO-2001052935 | Jul 2001 | WO |
WO-2001054753 | Aug 2001 | WO |
WO-2002016905 | Feb 2002 | WO |
WO-2002058537 | Aug 2002 | WO |
WO-2003076893 | Sep 2003 | WO |
WO-2003082091 | Oct 2003 | WO |
WO-2004060455 | Jul 2004 | WO |
WO-2005010756 | Feb 2005 | WO |
WO-2005065542 | Jul 2005 | WO |
WO-2006024671 | Mar 2006 | WO |
WO-2006081336 | Aug 2006 | WO |
WO-2006086423 | Aug 2006 | WO |
WO-2006124099 | Nov 2006 | WO |
WO-2007097754 | Aug 2007 | WO |
WO-2008086541 | Jul 2008 | WO |
Entry |
---|
Wang et al. Glucose Biosensors: 40 Years of Advances and Challenges Electroanalysis vol. 13, pp. 983-988 (Year: 2001). |
Armour, J. C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs”, Diabetes, vol. 39, 1990, pp. 1519-1526. |
Arnold, M. A., et al., “Selectivity Assessment of Noninvasive Glucose Measurements Based on Analysis of Multivariate Calibration Vectors”, Journal of Diabetes Science and Technology, vol. 1, No. 4, 2007, pp. 454-462. |
Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33. |
Blank, T. B., et al., “Clinical Results From a Non-Invasive Blood Glucose Monitor”, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10. |
Boyne, M. S., et al., “Timing of Changes in Interstitial and Venous Blood Glucose Measured With a Continuous Subcutaneous Glucose Sensor”, Diabetes, vol. 52, Nov. 2003, pp. 2790-2794. |
Bremer, T. M., et al., “Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418. |
Brooks, S. L., et al., “Development of an On-Line Glucose Sensor for Fermentation Monitoring”, Biosensors, vol. 3, 1987/88, pp. 45-56. |
Cass, A. E., et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose”, Analytical Chemistry, vol. 56, No. 4, 1984, 667-671. |
Cheyne, E. H., et al., “Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers”, Diabetes Technology & Therapeutics, vol. 4, No. 5, 2002, pp. 607-613. |
Choleau, C., et al., “Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2. Superiority of the One-Point Calibration Method”, Biosensors and Bioelectronics, vol. 17, No. 8, 2002, pp. 647-654. |
Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244. |
Eren-Oruklu, M., et al., “Estimation of Future Glucose Concentrations with Subject-Specific Recursive Linear Models”, Diabetes Technology & Therapeutics vol. 11(4), 2009, pp. 243-253. |
Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779. |
Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004. |
Georgescu, B., et al., “Real-Time Multimodel Tracking of Myocardium in Echocardiography Using Robust Information Fusion”, Medical Image Computing and Computer-Assisted Intervention, 2004, pp. 777-785. |
Goldman, J. M., et al., “Masimo Signal Extraction Pulse Oximetry”, Journal of Clinical Monitoring and Computing, vol. 16, No. 7, 2000, pp. 475-483. |
Guerci, B., et al., “Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs”, Diabetes Care, vol. 26, 2003, pp. 582-589. |
Hovorka, R., et al., “Nonlinear Model Predictive Control of Glucose Concentration in Subjects with Type 1 Diabetes”, Physiological Measurement, vol. 55, Jul. 2004, pp. 905-920. |
Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652. |
Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719. |
Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, pp. 198. |
Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, 2002, pp. 250. |
Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304. |
Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549. |
Kovatchev, B. P., et al., “Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors”, Diabetes Care, vol. 27, No. 8, 2004, pp. 1922-1928. |
Kovatchev, B. P., et al., “Graphical and Numerical Evaluation of Continuous Glucose Sensing Time Lag”, Diabetes Technology & Therapeutics, vol. 11, No. 3, Feb. 2009, pp. 139-143. |
Kuure-Kinsey, M., et al., “A Dual-Rate Kalman Filter for Continuous Glucose Monitoring”, Proceedings of the 28th IEEE, EMBS Annual International Conference, New York City, 2006, pp. 63-66. |
Lodwig, V., et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria”, Diabetes Technology & Therapeutics, vol. 5, No. 4, 2003, pp. 573-587. |
Lortz, J., et al., “What is Bluetooth? We Explain the Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74. |
Maher, “A Method for Extrapolation of Missing Digital Audio Data”, Preprints of Papers Presented at the AES Convention, 1993, pp. 1-19. |
Maher, “Audio Enhancement using Nonlinear Time-Frequency Filtering”, AES 26th International Conference, 2005, pp. 1-9. |
Malin, S. F., et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectoscopy”, Clinical Chemistry, vol. 45, No. 9, 1999, pp. 1651-1658. |
Mcgarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger”, TheraSense Inc., 2001, 16 Pages. |
Mcgarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376. |
Mckean, B. D., et al., “A Telemetry—Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988, pp. 526-532. |
Morbiducci, U, et al., “Improved Usability of the Minimal Model of Insulin Sensitivity Based on an Automated Approach and Genetic Algorithms for Parameter Estimation”, Clinical Science, vol. 112, 2007, pp. 257-263. |
Mougiakakou, et al., “A Real Time Simulation Model of Glucose-Insulin Metabolism for Type 1 Diabetes Patients”, Proceedings of the 2005 IEEE, 2005, pp. 298-301. |
Panteleon, A. E., et al., “The Role of the Independent Variable to Glucose Sensor Calibration”, Diabetes Technology & Therapeutics, vol. 5, No. 3, 2003, pp. 401-410. |
Parker, R., et al., “Robust H∞ Glucose Control in Diabetes Using a Physiological Model”, AIChE Journal, vol. 46, No. 12, 2000, pp. 2537-2549. |
Pickup, J., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88, pp. 335-346. |
Pickup, J., et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer”, Diabetologia, vol. 32, 1989, pp. 213-217. |
Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels”, Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272. |
Quinn, C. P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors”, The American Physiological Society, 1995, E155-E161. |
Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241. |
Sakakida, M., et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations”, Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158. |
Sakakida, M., et al., “Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane”, Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322. |
Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308. |
Schmidtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299. |
Shaw, G. W., et al., “In Vitro Testing of a Simply Constmcted, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406. |
Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas”, Diabetologia, vol. 24, 1983, pp. 179-184. |
Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers”, Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20. |
Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313. |
Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210. |
Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301. |
Shichiri, M., et al., “Wearable Artificial Endocrine Pancreas With Needle-Type Glucose Sensor”, The Lancet, 1982, pp. 1129-1131. |
Shults, M. C., et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942. |
Steil, G. M., et al., “Closed-Loop Insulin Delivery—the Path of Physiological Glucose Control”, Advanced Drug Delivery Reviews, vol. 56, 2004, pp. 125-144. |
Steil, G. M., et al., “Determination of Plasma Glucose During Rapid Glucose Excursions with a Subcutaneous Glucose Sensor”, Diabetes Technology & Therapeutics, vol. 5, No. 1, 2003, pp. 27-31. |
Sternberg, R., et al., “Study and Development of Multilayer Needle-Type Enzyme-Based Glucose Microsensors”, Biosensors, vol. 4, 1988, pp. 27-40. |
Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261. |
Turner, A., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors, vol. 1, 1985, pp. 85-115. |
Updike, S. J., et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, 1997, pp. 117-137. |
Velho, G., et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964. |
Whipple, G., “Low Residual Noise Speech Enhancement Utilizing Time-Frequency”, Proceedings of the International Conference on Acoustics, Speech, and Signal Processing, vol. 19, 1994, pp. 15-18. |
Wilson, G. S., et al., “Progress Toward the Development of an Implantable Sensor for Glucose”, Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617. |
Wolfe, P. J., et al., “Interpolation of Missing Data Values for Audio Signal Restoration Using a Gabor Regression Model”, 2005 IEEE International Conference on Acoustics, Speech, and Signal Processing, vol. 5, 2005, pp. 517-520. |
PCT Application No. PCT/US2010/022669, International Preliminary Report on Patentability and Written Opinion of The International Searching Authority dated Aug. 11, 2011. |
PCT Application No. PCT/US2010/022669, International Search Report and Written Opinion of The International Searching Authority dated Mar. 23, 2010. |
U.S. Appl. No. 12/362,479, Notice of Allowance dated May 25, 2012. |
U.S. Appl. No. 12/362,479, Office Action dated Oct. 7, 2011. |
U.S. Appl. No. 13/550,515, Notice of Allowance dated Jun. 24, 2013. |
U.S. Appl. No. 13/550,515, Office Action dated Dec. 19, 2012. |
U.S. Appl. No. 14/017,195, Advisory Action dated Feb. 22, 2017. |
U.S. Appl. No. 14/017,195, Notice of Allowance dated Jun. 27, 2018. |
U.S. Appl. No. 14/017,195, Office Action dated Dec. 15, 2016. |
U.S. Appl. No. 14/017,195, Office Action dated Jul. 22, 2016. |
U.S. Appl. No. 14/017,195, Office Action dated Sep. 26, 2017. |
U.S. Appl. No. 14/077,004, Office Action dated Jul. 26, 2016. |
Number | Date | Country | |
---|---|---|---|
20190035488 A1 | Jan 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14017195 | Sep 2013 | US |
Child | 16147087 | US | |
Parent | 13550515 | Jul 2012 | US |
Child | 14017195 | US | |
Parent | 12362479 | Jan 2009 | US |
Child | 13550515 | US |